<!DOCTYPE html>
<html lang="en" dir="ltr" class="client-nojs">
<head>
<meta charset="UTF-8" />
<title>Chronic myelogenous leukemia - Wikipedia, the free encyclopedia</title>
<meta name="generator" content="MediaWiki 1.26wmf13" />
<link rel="alternate" href="android-app://org.wikipedia/http/en.m.wikipedia.org/wiki/Chronic_myelogenous_leukemia" />
<link rel="alternate" type="application/x-wiki" title="Edit this page" href="/w/index.php?title=Chronic_myelogenous_leukemia&amp;action=edit" />
<link rel="edit" title="Edit this page" href="/w/index.php?title=Chronic_myelogenous_leukemia&amp;action=edit" />
<link rel="apple-touch-icon" href="/static/apple-touch/wikipedia.png" />
<link rel="shortcut icon" href="/static/favicon/wikipedia.ico" />
<link rel="search" type="application/opensearchdescription+xml" href="/w/opensearch_desc.php" title="Wikipedia (en)" />
<link rel="EditURI" type="application/rsd+xml" href="//en.wikipedia.org/w/api.php?action=rsd" />
<link rel="alternate" hreflang="x-default" href="/wiki/Chronic_myelogenous_leukemia" />
<link rel="copyright" href="//creativecommons.org/licenses/by-sa/3.0/" />
<link rel="alternate" type="application/atom+xml" title="Wikipedia Atom feed" href="/w/index.php?title=Special:RecentChanges&amp;feed=atom" />
<link rel="canonical" href="https://en.wikipedia.org/wiki/Chronic_myelogenous_leukemia" />
<link rel="stylesheet" href="//en.wikipedia.org/w/load.php?debug=false&amp;lang=en&amp;modules=ext.uls.nojs%7Cext.visualEditor.viewPageTarget.noscript%7Cext.wikihiero%7Cmediawiki.legacy.commonPrint%2Cshared%7Cmediawiki.sectionAnchor%7Cmediawiki.skinning.interface%7Cmediawiki.ui.button%7Cskins.vector.styles%7Cwikibase.client.init&amp;only=styles&amp;skin=vector&amp;*" />
<meta name="ResourceLoaderDynamicStyles" content="" />
<link rel="stylesheet" href="//en.wikipedia.org/w/load.php?debug=false&amp;lang=en&amp;modules=site&amp;only=styles&amp;skin=vector&amp;*" />
<style>a:lang(ar),a:lang(kk-arab),a:lang(mzn),a:lang(ps),a:lang(ur){text-decoration:none}
/* cache key: global:resourceloader:filter:minify-css:7:de1ab5287c9076b96eedd3f97a84a7b6 */</style>
<script src="//en.wikipedia.org/w/load.php?debug=false&amp;lang=en&amp;modules=startup&amp;only=scripts&amp;skin=vector&amp;*"></script>
<script>if(window.mw){
mw.config.set({"wgCanonicalNamespace":"","wgCanonicalSpecialPageName":false,"wgNamespaceNumber":0,"wgPageName":"Chronic_myelogenous_leukemia","wgTitle":"Chronic myelogenous leukemia","wgCurRevisionId":669549241,"wgRevisionId":669549241,"wgArticleId":559874,"wgIsArticle":true,"wgIsRedirect":false,"wgAction":"view","wgUserName":null,"wgUserGroups":["*"],"wgCategories":["Articles with inconsistent citation formats","Articles with contributors link","Articles to be expanded from August 2012","All articles to be expanded","All articles with unsourced statements","Articles with unsourced statements from December 2012","Articles that use a Medicine navs subtemplate","Chronic myeloid leukemia"],"wgBreakFrames":false,"wgPageContentLanguage":"en","wgPageContentModel":"wikitext","wgSeparatorTransformTable":["",""],"wgDigitTransformTable":["",""],"wgDefaultDateFormat":"dmy","wgMonthNames":["","January","February","March","April","May","June","July","August","September","October","November","December"],"wgMonthNamesShort":["","Jan","Feb","Mar","Apr","May","Jun","Jul","Aug","Sep","Oct","Nov","Dec"],"wgRelevantPageName":"Chronic_myelogenous_leukemia","wgRelevantArticleId":559874,"wgIsProbablyEditable":true,"wgRestrictionEdit":[],"wgRestrictionMove":[],"wgMediaViewerOnClick":true,"wgMediaViewerEnabledByDefault":true,"wikilove-recipient":"","wikilove-anon":0,"wgPoweredByHHVM":true,"wgWikiEditorEnabledModules":{"toolbar":true,"dialogs":true,"hidesig":true,"preview":false,"publish":false},"wgBetaFeaturesFeatures":[],"wgVisualEditor":{"pageLanguageCode":"en","pageLanguageDir":"ltr","usePageImages":true,"usePageDescriptions":true},"wgGatherShouldShowTutorial":true,"wgGatherPageImageThumbnail":"//upload.wikimedia.org/wikipedia/commons/thumb/d/dc/Bcrablmet.jpg/87px-Bcrablmet.jpg","wgULSAcceptLanguageList":[],"wgULSCurrentAutonym":"English","wgFlaggedRevsParams":{"tags":{"status":{"levels":1,"quality":2,"pristine":3}}},"wgStableRevisionId":null,"wgCategoryTreePageCategoryOptions":"{\"mode\":0,\"hideprefix\":20,\"showcount\":true,\"namespaces\":false}","wgNoticeProject":"wikipedia","wgWikibaseItemId":"Q729735"});
}</script><script>if(window.mw){
mw.loader.implement("user.options",function($,jQuery){mw.user.options.set({"variant":"en"});});
/* cache key: global:resourceloader:filter:minify-js:7:b2706269305541eba923c165462b22c4 */
}</script>
<script>if(window.mw){
mw.loader.implement("user.tokens",function($,jQuery){mw.user.tokens.set({"editToken":"+\\","patrolToken":"+\\","watchToken":"+\\"});});
}</script>
<script>if(window.mw){
mw.loader.load(["mediawiki.page.startup","mediawiki.legacy.wikibits","mediawiki.legacy.ajax","ext.centralauth.centralautologin","mmv.head","ext.imageMetrics.head","ext.visualEditor.viewPageTarget.init","ext.uls.init","ext.uls.interface","ext.centralNotice.bannerController","skins.vector.js"]);
}</script>
<link rel="dns-prefetch" href="//meta.wikimedia.org" />
<!--[if lt IE 7]><style type="text/css">body{behavior:url("/w/static/1.26wmf13/skins/Vector/csshover.min.htc")}</style><![endif]-->
</head>
<body class="mediawiki ltr sitedir-ltr ns-0 ns-subject page-Chronic_myelogenous_leukemia skin-vector action-view">
		<div id="mw-page-base" class="noprint"></div>
		<div id="mw-head-base" class="noprint"></div>
		<div id="content" class="mw-body" role="main">
			<a id="top"></a>

							<div id="siteNotice"><!-- CentralNotice --></div>
						<div class="mw-indicators">
</div>
			<h1 id="firstHeading" class="firstHeading" lang="en">Chronic myelogenous leukemia</h1>
									<div id="bodyContent" class="mw-body-content">
									<div id="siteSub">From Wikipedia, the free encyclopedia</div>
								<div id="contentSub"></div>
												<div id="jump-to-nav" class="mw-jump">
					Jump to:					<a href="#mw-head">navigation</a>, 					<a href="#p-search">search</a>
				</div>
				<div id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><table class="infobox" style="width:22em">
<tr>
<th colspan="2" style="text-align:center;font-size:125%;font-weight:bold;background-color: lightgrey">Chronic myelogenous leukemia</th>
</tr>
<tr>
<td colspan="2" style="text-align:center"><a href="/wiki/File:Bcrablmet.jpg" class="image"><img alt="Bcrablmet.jpg" src="//upload.wikimedia.org/wikipedia/commons/d/dc/Bcrablmet.jpg" width="213" height="244" data-file-width="213" data-file-height="244" /></a>
<div>The <a href="/wiki/Philadelphia_chromosome" title="Philadelphia chromosome">Philadelphia chromosome</a> as seen by metaphase <a href="/wiki/Fluorescent_in_situ_hybridization" title="Fluorescent in situ hybridization" class="mw-redirect">FISH</a>.</div>
</td>
</tr>
<tr>
<th colspan="2" style="text-align:center">Classification and external resources</th>
</tr>
<tr>
<th scope="row"><a href="/wiki/Specialty_(medicine)" title="Specialty (medicine)">Specialty</a></th>
<td><a href="/wiki/Hematology" title="Hematology">Hematology</a> and <a href="/wiki/Oncology" title="Oncology">oncology</a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/International_Statistical_Classification_of_Diseases_and_Related_Health_Problems" title="International Statistical Classification of Diseases and Related Health Problems">ICD</a>-<a href="/wiki/ICD-10" title="ICD-10">10</a></th>
<td><a rel="nofollow" class="external text" href="http://apps.who.int/classifications/icd10/browse/2015/en#/C92.1">C92.1</a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/International_Statistical_Classification_of_Diseases_and_Related_Health_Problems" title="International Statistical Classification of Diseases and Related Health Problems">ICD</a>-<a href="/wiki/List_of_ICD-9_codes" title="List of ICD-9 codes">9-CM</a></th>
<td><a rel="nofollow" class="external text" href="http://www.icd9data.com/getICD9Code.ashx?icd9=205.1">205.1</a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/International_Classification_of_Diseases_for_Oncology" title="International Classification of Diseases for Oncology">ICD-O</a></th>
<td><a href="/wiki/ICD-O" title="ICD-O" class="mw-redirect">M</a><a rel="nofollow" class="external text" href="http://www.progenetix.net/progenetix/I98753/">9875/3</a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/Diseases_Database" title="Diseases Database">DiseasesDB</a></th>
<td><a rel="nofollow" class="external text" href="http://www.diseasesdatabase.com/ddb2659.htm">2659</a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/MedlinePlus" title="MedlinePlus">MedlinePlus</a></th>
<td><a rel="nofollow" class="external text" href="http://www.nlm.nih.gov/medlineplus/ency/article/000570.htm">000570</a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/EMedicine" title="EMedicine">eMedicine</a></th>
<td><a rel="nofollow" class="external text" href="http://www.emedicine.com/med/topic371.htm">med/371</a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/National_Cancer_Institute" title="National Cancer Institute">NCI</a></th>
<td><a rel="nofollow" class="external text" href="http://www.cancer.gov/cancertopics/types/leukemia">Chronic myelogenous leukemia</a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/Medical_Subject_Headings" title="Medical Subject Headings">MeSH</a></th>
<td><a rel="nofollow" class="external text" href="//www.nlm.nih.gov/cgi/mesh/2015/MB_cgi?field=uid&amp;term=D015464">D015464</a></td>
</tr>
</table>
<p><b>Chronic myelogenous</b> (or <b>myeloid</b> or <b>myelocytic</b>) <b>leukemia</b> (<b>CML</b>), also known as <b>chronic granulocytic leukemia</b> (<b>CGL</b>), is a cancer of the <a href="/wiki/White_blood_cell" title="White blood cell">white blood cells</a>. It is a form of <a href="/wiki/Leukemia" title="Leukemia">leukemia</a> characterized by the increased and unregulated growth of predominantly <a href="/wiki/Myeloid" title="Myeloid">myeloid</a> cells in the <a href="/wiki/Bone_marrow" title="Bone marrow">bone marrow</a> and the accumulation of these cells in the blood. CML is a clonal bone marrow <a href="/wiki/Stem_cell" title="Stem cell">stem cell</a> disorder in which a proliferation of mature <a href="/wiki/Granulocyte" title="Granulocyte">granulocytes</a> (<a href="/wiki/Neutrophil" title="Neutrophil" class="mw-redirect">neutrophils</a>, <a href="/wiki/Eosinophil" title="Eosinophil" class="mw-redirect">eosinophils</a> and <a href="/wiki/Basophil" title="Basophil" class="mw-redirect">basophils</a>) and their precursors is found. It is a type of <a href="/wiki/Myeloproliferative_disease" title="Myeloproliferative disease" class="mw-redirect">myeloproliferative disease</a> associated with a characteristic <a href="/wiki/Chromosomal_translocation" title="Chromosomal translocation">chromosomal translocation</a> called the <a href="/wiki/Philadelphia_chromosome" title="Philadelphia chromosome">Philadelphia chromosome</a>. CML is now largely treated with targeted drugs called <a href="/wiki/Tyrosine_kinase_inhibitor" title="Tyrosine kinase inhibitor" class="mw-redirect">tyrosine kinase inhibitors</a> (TKIs) which have led to dramatically improved long-term survival rates since the introduction of the first such agent in 2001. These drugs have revolutionized treatment of this disease and allow most patients to have a good quality of life when compared to the former chemotherapy drugs. In Western countries it accounts for 15-20% of all adult leukemias and 14% of leukemias overall (including the pediatric population).<sup id="cite_ref-MSR_1-0" class="reference"><a href="#cite_note-MSR-1"><span>[</span>1<span>]</span></a></sup></p>
<p></p>
<div id="toc" class="toc">
<div id="toctitle">
<h2>Contents</h2>
</div>
<ul>
<li class="toclevel-1 tocsection-1"><a href="#Signs_and_symptoms"><span class="tocnumber">1</span> <span class="toctext">Signs and symptoms</span></a></li>
<li class="toclevel-1 tocsection-2"><a href="#Cause"><span class="tocnumber">2</span> <span class="toctext">Cause</span></a>
<ul>
<li class="toclevel-2 tocsection-3"><a href="#Risk_factors"><span class="tocnumber">2.1</span> <span class="toctext">Risk factors</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-4"><a href="#Diagnosis"><span class="tocnumber">3</span> <span class="toctext">Diagnosis</span></a></li>
<li class="toclevel-1 tocsection-5"><a href="#Pathophysiology"><span class="tocnumber">4</span> <span class="toctext">Pathophysiology</span></a></li>
<li class="toclevel-1 tocsection-6"><a href="#Classification"><span class="tocnumber">5</span> <span class="toctext">Classification</span></a>
<ul>
<li class="toclevel-2 tocsection-7"><a href="#Chronic_phase"><span class="tocnumber">5.1</span> <span class="toctext">Chronic phase</span></a></li>
<li class="toclevel-2 tocsection-8"><a href="#Accelerated_phase"><span class="tocnumber">5.2</span> <span class="toctext">Accelerated phase</span></a></li>
<li class="toclevel-2 tocsection-9"><a href="#Blast_crisis"><span class="tocnumber">5.3</span> <span class="toctext">Blast crisis</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-10"><a href="#Treatment"><span class="tocnumber">6</span> <span class="toctext">Treatment</span></a>
<ul>
<li class="toclevel-2 tocsection-11"><a href="#Chronic_phase_2"><span class="tocnumber">6.1</span> <span class="toctext">Chronic phase</span></a>
<ul>
<li class="toclevel-3 tocsection-12"><a href="#Imatinib"><span class="tocnumber">6.1.1</span> <span class="toctext">Imatinib</span></a></li>
<li class="toclevel-3 tocsection-13"><a href="#Dasatinib.2C_nilotinib_and_radotinib"><span class="tocnumber">6.1.2</span> <span class="toctext">Dasatinib, nilotinib and radotinib</span></a></li>
<li class="toclevel-3 tocsection-14"><a href="#Treatment-resistant_CML"><span class="tocnumber">6.1.3</span> <span class="toctext">Treatment-resistant CML</span></a></li>
</ul>
</li>
<li class="toclevel-2 tocsection-15"><a href="#Vaccination"><span class="tocnumber">6.2</span> <span class="toctext">Vaccination</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-16"><a href="#Prognosis"><span class="tocnumber">7</span> <span class="toctext">Prognosis</span></a></li>
<li class="toclevel-1 tocsection-17"><a href="#Epidemiology"><span class="tocnumber">8</span> <span class="toctext">Epidemiology</span></a>
<ul>
<li class="toclevel-2 tocsection-18"><a href="#UK"><span class="tocnumber">8.1</span> <span class="toctext">UK</span></a></li>
<li class="toclevel-2 tocsection-19"><a href="#US"><span class="tocnumber">8.2</span> <span class="toctext">US</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-20"><a href="#References"><span class="tocnumber">9</span> <span class="toctext">References</span></a></li>
<li class="toclevel-1 tocsection-21"><a href="#External_links"><span class="tocnumber">10</span> <span class="toctext">External links</span></a></li>
</ul>
</div>
<p></p>
<h2><span class="mw-headline" id="Signs_and_symptoms">Signs and symptoms</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Chronic_myelogenous_leukemia&amp;action=edit&amp;section=1" title="Edit section: Signs and symptoms">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>The way CML presents depends on the stage of the disease at diagnosis as it has been known to skip stages in some cases.<sup id="cite_ref-PMSR_2-0" class="reference"><a href="#cite_note-PMSR-2"><span>[</span>2<span>]</span></a></sup></p>
<p>Most patients (~90%) are diagnosed during the chronic stage which is most often asymptomatic. In these cases it may be diagnosed incidentally with an elevated <a href="/wiki/White_blood_cell" title="White blood cell">white blood cell</a> count on a routine laboratory test. It can also present with symptoms indicative of enlarged spleen and liver and the resulting upper quadrant pain this causes. The enlarged spleen may put pressure on the stomach causing a loss of appetite and resulting weight loss. It may also present with mild fever and night sweats due to an elevated basal level of metabolism.<sup id="cite_ref-PMSR_2-1" class="reference"><a href="#cite_note-PMSR-2"><span>[</span>2<span>]</span></a></sup></p>
<p>Some (&lt;10%) are diagnosed during the accelerated stage which most often presents bleeding, <a href="/wiki/Petechiae" title="Petechiae" class="mw-redirect">petechiae</a> and <a href="/wiki/Ecchymosis" title="Ecchymosis">ecchymosis</a>.<sup id="cite_ref-PMSR_2-2" class="reference"><a href="#cite_note-PMSR-2"><span>[</span>2<span>]</span></a></sup> In these patients fevers are most commonly the result of opportunistic infections.<sup id="cite_ref-PMSR_2-3" class="reference"><a href="#cite_note-PMSR-2"><span>[</span>2<span>]</span></a></sup></p>
<p>Some patients are initially diagnosed in the blast phase in which the symptoms are most likely fever, bone pain and an increase in bone marrow fibrosis.<sup id="cite_ref-PMSR_2-4" class="reference"><a href="#cite_note-PMSR-2"><span>[</span>2<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Cause">Cause</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Chronic_myelogenous_leukemia&amp;action=edit&amp;section=2" title="Edit section: Cause">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>In most cases no obvious cause for CML can be isolated.<sup id="cite_ref-MolHem_3-0" class="reference"><a href="#cite_note-MolHem-3"><span>[</span>3<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Risk_factors">Risk factors</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Chronic_myelogenous_leukemia&amp;action=edit&amp;section=3" title="Edit section: Risk factors">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>It is more common in males than in females (male to female ratio of 1.4:1) and appears more common in the elderly with a median age at diagnosis of 65 years.<sup id="cite_ref-MolHem_3-1" class="reference"><a href="#cite_note-MolHem-3"><span>[</span>3<span>]</span></a></sup> Exposure to ionising radiation appears to be a risk factor, based on a 50 fold higher incidence of CML in Hiroshima and Nagasaki nuclear bombing survivors.<sup id="cite_ref-MolHem_3-2" class="reference"><a href="#cite_note-MolHem-3"><span>[</span>3<span>]</span></a></sup> The rate of CML in these individuals seems to peak about 10 years after the exposure.<sup id="cite_ref-MolHem_3-3" class="reference"><a href="#cite_note-MolHem-3"><span>[</span>3<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Diagnosis">Diagnosis</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Chronic_myelogenous_leukemia&amp;action=edit&amp;section=4" title="Edit section: Diagnosis">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<div class="thumb tright">
<div class="thumbinner" style="width:222px;"><a href="/wiki/File:Chronic_Myeloid_Leukemia_smear_2009-04-09.JPG" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/f/fc/Chronic_Myeloid_Leukemia_smear_2009-04-09.JPG/220px-Chronic_Myeloid_Leukemia_smear_2009-04-09.JPG" width="220" height="165" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/f/fc/Chronic_Myeloid_Leukemia_smear_2009-04-09.JPG/330px-Chronic_Myeloid_Leukemia_smear_2009-04-09.JPG 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/f/fc/Chronic_Myeloid_Leukemia_smear_2009-04-09.JPG/440px-Chronic_Myeloid_Leukemia_smear_2009-04-09.JPG 2x" data-file-width="1638" data-file-height="1228" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:Chronic_Myeloid_Leukemia_smear_2009-04-09.JPG" class="internal" title="Enlarge"></a></div>
Peripheral blood (MGG stain): marked leucocytosis with granulocyte left shift</div>
</div>
</div>
<div class="thumb tright">
<div class="thumbinner" style="width:222px;"><a href="/wiki/File:Hypolobated_small_megakaryocyte.jpg" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/7/75/Hypolobated_small_megakaryocyte.jpg/220px-Hypolobated_small_megakaryocyte.jpg" width="220" height="166" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/7/75/Hypolobated_small_megakaryocyte.jpg/330px-Hypolobated_small_megakaryocyte.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/7/75/Hypolobated_small_megakaryocyte.jpg/440px-Hypolobated_small_megakaryocyte.jpg 2x" data-file-width="1360" data-file-height="1024" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:Hypolobated_small_megakaryocyte.jpg" class="internal" title="Enlarge"></a></div>
A small, hypolobated megakaryocyte (center of field) in a bone marrow aspirate, typically of chronic myelogenous leukemia.</div>
</div>
</div>
<p>CML is often suspected on the basis of a <a href="/wiki/Complete_blood_count" title="Complete blood count">complete blood count</a>, which shows increased <a href="/wiki/Granulocyte" title="Granulocyte">granulocytes</a> of all types, typically including mature <a href="/wiki/Myelocyte" title="Myelocyte">myeloid cells</a>. <a href="/wiki/Basophil" title="Basophil" class="mw-redirect">Basophils</a> and <a href="/wiki/Eosinophil" title="Eosinophil" class="mw-redirect">eosinophils</a> are almost universally increased; this feature may help differentiate CML from a <a href="/wiki/Leukemoid_reaction" title="Leukemoid reaction">leukemoid reaction</a>. A <a href="/wiki/Bone_marrow_biopsy" title="Bone marrow biopsy" class="mw-redirect">bone marrow biopsy</a> is often performed as part of the evaluation for CML, and CML is diagnosed by detecting the <a href="/wiki/Philadelphia_chromosome" title="Philadelphia chromosome">Philadelphia chromosome</a>. This characteristic <a href="/wiki/Chromosome_abnormality" title="Chromosome abnormality">chromosomal abnormality</a> can be detected by routine <a href="/wiki/Cytogenetics" title="Cytogenetics">cytogenetics</a>, by <a href="/wiki/Fluorescent_in_situ_hybridization" title="Fluorescent in situ hybridization" class="mw-redirect">fluorescent in situ hybridization</a>, or by <a href="/wiki/Polymerase_chain_reaction" title="Polymerase chain reaction">PCR</a> for the bcr-abl fusion gene.<sup id="cite_ref-Tefferi_4-0" class="reference"><a href="#cite_note-Tefferi-4"><span>[</span>4<span>]</span></a></sup></p>
<p>Controversy exists over so-called <i>Ph-negative</i> CML, or cases of suspected CML in which the Philadelphia chromosome cannot be detected. Many such patients in fact have complex chromosomal abnormalities that mask the (9;22) translocation, or have evidence of the translocation by <a href="/wiki/Fluorescent_in_situ_hybridization" title="Fluorescent in situ hybridization" class="mw-redirect">FISH</a> or <a href="/wiki/RT-PCR" title="RT-PCR" class="mw-redirect">RT-PCR</a> in spite of normal routine karyotyping.<sup id="cite_ref-5" class="reference"><a href="#cite_note-5"><span>[</span>5<span>]</span></a></sup> The small subset of patients without detectable molecular evidence of bcr-abl fusion may be better classified as having an undifferentiated <a href="/wiki/Myelodysplastic/myeloproliferative_disorder" title="Myelodysplastic/myeloproliferative disorder" class="mw-redirect">myelodysplastic/myeloproliferative disorder</a>, as their clinical course tends to be different from patients with CML.<sup id="cite_ref-WHO_6-0" class="reference"><a href="#cite_note-WHO-6"><span>[</span>6<span>]</span></a></sup></p>
<p>CML must be distinguished from a <a href="/wiki/Leukemoid_reaction" title="Leukemoid reaction">leukemoid reaction</a>, which can have a similar appearance on a <a href="/wiki/Blood_film" title="Blood film">blood smear</a>.<sup id="cite_ref-Tefferi_4-1" class="reference"><a href="#cite_note-Tefferi-4"><span>[</span>4<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Pathophysiology">Pathophysiology</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Chronic_myelogenous_leukemia&amp;action=edit&amp;section=5" title="Edit section: Pathophysiology">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>CML was the first cancer to be linked to a clear genetic abnormality, the <a href="/wiki/Chromosomal_translocation" title="Chromosomal translocation">chromosomal translocation</a> known as the <a href="/wiki/Philadelphia_chromosome" title="Philadelphia chromosome">Philadelphia chromosome</a>. This chromosomal abnormality is so named because it was first discovered and described in 1960 by two scientists from <a href="/wiki/Philadelphia,_Pennsylvania" title="Philadelphia, Pennsylvania" class="mw-redirect">Philadelphia, Pennsylvania</a>, USA: Peter Nowell of the <a href="/wiki/University_of_Pennsylvania" title="University of Pennsylvania">University of Pennsylvania</a> and David Hungerford of <a href="/wiki/Fox_Chase_Cancer_Center" title="Fox Chase Cancer Center">Fox Chase Cancer Center</a>.<sup id="cite_ref-7" class="reference"><a href="#cite_note-7"><span>[</span>7<span>]</span></a></sup></p>
<div class="thumb tright">
<div class="thumbinner" style="width:222px;"><a href="/wiki/File:Philadelphia_chromosome.jpg" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/9/90/Philadelphia_chromosome.jpg/220px-Philadelphia_chromosome.jpg" width="220" height="116" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/9/90/Philadelphia_chromosome.jpg/330px-Philadelphia_chromosome.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/9/90/Philadelphia_chromosome.jpg 2x" data-file-width="401" data-file-height="211" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:Philadelphia_chromosome.jpg" class="internal" title="Enlarge"></a></div>
Diagram showing the translocation found in the Philadelphia chromosome</div>
</div>
</div>
<p>In this translocation, parts of two chromosomes (the 9th and 22nd) switch places. As a result, part of the <a href="/wiki/BCR_gene" title="BCR gene" class="mw-redirect">BCR</a> ("breakpoint cluster region") gene from chromosome 22 is fused with the <a href="/wiki/Abl_gene" title="Abl gene" class="mw-redirect">ABL</a> gene on chromosome 9. This abnormal "fusion" gene generates a protein of p210 or sometimes p185 weight (p210 is short for 210 <a href="/wiki/KDa" title="KDa" class="mw-redirect">kDa</a> protein, a shorthand used for characterizing proteins based solely on size). Because abl carries a domain that can add <a href="/wiki/Phosphate" title="Phosphate">phosphate</a> groups to tyrosine residues (a <a href="/wiki/Tyrosine_kinase" title="Tyrosine kinase">tyrosine kinase</a>), the <i>bcr-abl</i> fusion gene product is also a tyrosine kinase.<sup id="cite_ref-Faderl1990_8-0" class="reference"><a href="#cite_note-Faderl1990-8"><span>[</span>8<span>]</span></a></sup><sup id="cite_ref-Hehlmann_9-0" class="reference"><a href="#cite_note-Hehlmann-9"><span>[</span>9<span>]</span></a></sup></p>
<div class="thumb tright">
<div class="thumbinner" style="width:222px;"><a href="/wiki/File:Diagram_showing_which_cells_CML_can_start_in_CRUK_388.svg" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/8/81/Diagram_showing_which_cells_CML_can_start_in_CRUK_388.svg/220px-Diagram_showing_which_cells_CML_can_start_in_CRUK_388.svg.png" width="220" height="209" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/8/81/Diagram_showing_which_cells_CML_can_start_in_CRUK_388.svg/330px-Diagram_showing_which_cells_CML_can_start_in_CRUK_388.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/8/81/Diagram_showing_which_cells_CML_can_start_in_CRUK_388.svg/440px-Diagram_showing_which_cells_CML_can_start_in_CRUK_388.svg.png 2x" data-file-width="364" data-file-height="346" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:Diagram_showing_which_cells_CML_can_start_in_CRUK_388.svg" class="internal" title="Enlarge"></a></div>
Diagram showing the cells CML can develop from</div>
</div>
</div>
<p>The fused BCR-ABL protein interacts with the <a href="/wiki/Interleukin-3_receptor" title="Interleukin-3 receptor">interleukin 3beta(c) receptor</a> subunit. The BCR-ABL transcript is continuously active and does not require activation by other cellular messaging proteins. In turn, BCR-ABL activates a cascade of proteins that control the <a href="/wiki/Cell_cycle" title="Cell cycle">cell cycle</a>, speeding up cell division. Moreover, the BCR-ABL protein inhibits <a href="/wiki/DNA_repair" title="DNA repair">DNA repair</a>, causing genomic instability and making the cell more susceptible to developing further genetic abnormalities. The action of the BCR-ABL protein is the pathophysiologic cause of chronic myelogenous leukemia. With improved understanding of the nature of the BCR-ABL protein and its action as a tyrosine kinase, <a href="/wiki/Targeted_therapy" title="Targeted therapy">targeted therapies</a> (the first of which was <a href="/wiki/Imatinib_mesylate" title="Imatinib mesylate" class="mw-redirect">imatinib mesylate</a>) that specifically inhibit the activity of the BCR-ABL protein have been developed. These tyrosine kinase inhibitors can induce complete remissions in CML, confirming the central importance of bcr-abl as the cause of CML.<sup id="cite_ref-Hehlmann_9-1" class="reference"><a href="#cite_note-Hehlmann-9"><span>[</span>9<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Classification">Classification</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Chronic_myelogenous_leukemia&amp;action=edit&amp;section=6" title="Edit section: Classification">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>CML is often divided into three phases based on clinical characteristics and laboratory findings. In the absence of intervention, CML typically begins in the <i>chronic</i> phase, and over the course of several years progresses to an <i>accelerated</i> phase and ultimately to a <i>blast crisis</i>. Blast crisis is the terminal phase of CML and clinically behaves like an <a href="/wiki/Acute_leukemia" title="Acute leukemia">acute leukemia</a>. Drug treatment will usually stop this progression if started early. One of the drivers of the progression from chronic phase through acceleration and blast crisis is the acquisition of new chromosomal abnormalities (in addition to the Philadelphia chromosome).<sup id="cite_ref-Faderl1990_8-1" class="reference"><a href="#cite_note-Faderl1990-8"><span>[</span>8<span>]</span></a></sup> Some patients may already be in the accelerated phase or blast crisis by the time they are diagnosed.<sup id="cite_ref-Tefferi_4-2" class="reference"><a href="#cite_note-Tefferi-4"><span>[</span>4<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Chronic_phase">Chronic phase</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Chronic_myelogenous_leukemia&amp;action=edit&amp;section=7" title="Edit section: Chronic phase">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Approximately 85% of patients with CML are in the chronic phase at the time of diagnosis. During this phase, patients are usually asymptomatic or have only mild symptoms of fatigue, left side pain, joint and/or hip pain, or abdominal fullness. The duration of chronic phase is variable and depends on how early the disease was diagnosed as well as the therapies used. In the absence of treatment, the disease progresses to an accelerated phase.<sup id="cite_ref-Tefferi_4-3" class="reference"><a href="#cite_note-Tefferi-4"><span>[</span>4<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Accelerated_phase">Accelerated phase</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Chronic_myelogenous_leukemia&amp;action=edit&amp;section=8" title="Edit section: Accelerated phase">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Criteria for diagnosing transition into the accelerated phase are somewhat variable; the most widely used criteria are those put forward by investigators at <a href="/wiki/M.D._Anderson_Cancer_Center" title="M.D. Anderson Cancer Center" class="mw-redirect">M.D. Anderson Cancer Center</a>,<sup id="cite_ref-10" class="reference"><a href="#cite_note-10"><span>[</span>10<span>]</span></a></sup> by Sokal et al.,<sup id="cite_ref-11" class="reference"><a href="#cite_note-11"><span>[</span>11<span>]</span></a></sup> and the <a href="/wiki/World_Health_Organization" title="World Health Organization">World Health Organization</a>.<sup id="cite_ref-WHO_6-1" class="reference"><a href="#cite_note-WHO-6"><span>[</span>6<span>]</span></a></sup><sup id="cite_ref-12" class="reference"><a href="#cite_note-12"><span>[</span>12<span>]</span></a></sup> The WHO criteria are perhaps most widely used, and define the accelerated phase by any of the following:</p>
<ul>
<li>10–19% <a href="/wiki/Myeloblast" title="Myeloblast">myeloblasts</a> in the blood or <a href="/wiki/Bone_marrow" title="Bone marrow">bone marrow</a></li>
<li>&gt;20% <a href="/wiki/Basophil" title="Basophil" class="mw-redirect">basophils</a> in the blood or bone marrow</li>
<li><a href="/wiki/Platelet" title="Platelet">Platelet</a> count &lt;100,000, unrelated to therapy</li>
<li>Platelet count &gt;1,000,000, unresponsive to therapy</li>
<li>Cytogenetic evolution with new abnormalities in addition to the Philadelphia chromosome</li>
<li>Increasing <a href="/wiki/Splenomegaly" title="Splenomegaly">splenomegaly</a> or white blood cell count, unresponsive to therapy</li>
</ul>
<p>The patient is considered to be in the accelerated phase if any of the above are present. The accelerated phase is significant because it signals that the disease is progressing and transformation to blast crisis is imminent. Drug treatment often becomes less effective in the advanced stages.<sup id="cite_ref-WHO_6-2" class="reference"><a href="#cite_note-WHO-6"><span>[</span>6<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Blast_crisis">Blast crisis</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Chronic_myelogenous_leukemia&amp;action=edit&amp;section=9" title="Edit section: Blast crisis">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Blast crisis is the final phase in the evolution of CML, and behaves like an <a href="/wiki/Acute_leukemia" title="Acute leukemia">acute leukemia</a>, with rapid progression and short survival.<sup id="cite_ref-Tefferi_4-4" class="reference"><a href="#cite_note-Tefferi-4"><span>[</span>4<span>]</span></a></sup> Blast crisis is diagnosed if any of the following are present in a patient with CML:<sup id="cite_ref-13" class="reference"><a href="#cite_note-13"><span>[</span>13<span>]</span></a></sup></p>
<ul>
<li>&gt;20% <a href="/wiki/Myeloblast" title="Myeloblast">myeloblasts</a> or <a href="/wiki/Lymphoblast" title="Lymphoblast">lymphoblasts</a> in the blood or bone marrow</li>
<li>Large clusters of blasts in the bone marrow on <a href="/wiki/Bone_marrow_biopsy" title="Bone marrow biopsy" class="mw-redirect">biopsy</a></li>
<li>Development of a <a href="/wiki/Chloroma" title="Chloroma" class="mw-redirect">chloroma</a> (solid focus of leukemia outside the bone marrow)</li>
</ul>
<h2><span class="mw-headline" id="Treatment">Treatment</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Chronic_myelogenous_leukemia&amp;action=edit&amp;section=10" title="Edit section: Treatment">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<table class="metadata plainlinks ambox mbox-small-left ambox-content" role="presentation">
<tr>
<td class="mbox-image"><a href="/wiki/File:Wiki_letter_w_cropped.svg" class="image"><img alt="[icon]" src="//upload.wikimedia.org/wikipedia/commons/thumb/1/1c/Wiki_letter_w_cropped.svg/20px-Wiki_letter_w_cropped.svg.png" width="20" height="14" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/1/1c/Wiki_letter_w_cropped.svg/30px-Wiki_letter_w_cropped.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/1/1c/Wiki_letter_w_cropped.svg/40px-Wiki_letter_w_cropped.svg.png 2x" data-file-width="44" data-file-height="31" /></a></td>
<td class="mbox-text"><span class="mbox-text-span">This section requires <a class="external text" href="//en.wikipedia.org/w/index.php?title=Chronic_myelogenous_leukemia&amp;action=edit">expansion</a>. <small><i>(August 2012)</i></small></span></td>
</tr>
</table>
<p>The only curative treatment for CML is a bone marrow transplant or an allogenic stem cell transplant.<sup id="cite_ref-TMSR_14-0" class="reference"><a href="#cite_note-TMSR-14"><span>[</span>14<span>]</span></a></sup> Other than this there are four major mainstays of treatment in CML: treatment with tyrosine kinase inhibitors, myelosuppressive or <a href="/w/index.php?title=Leukopheresis&amp;action=edit&amp;redlink=1" class="new" title="Leukopheresis (page does not exist)">leukopheresis</a> therapy (to counteract the <a href="/wiki/Leucocytosis" title="Leucocytosis" class="mw-redirect">leucocytosis</a> during early treatment), <a href="/wiki/Splenectomy" title="Splenectomy">splenectomy</a> and <a href="/wiki/Interferon_alfa-2b" title="Interferon alfa-2b" class="mw-redirect">interferon alfa-2b</a> treatment.<sup id="cite_ref-TMSR_14-1" class="reference"><a href="#cite_note-TMSR-14"><span>[</span>14<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Chronic_phase_2">Chronic phase</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Chronic_myelogenous_leukemia&amp;action=edit&amp;section=11" title="Edit section: Chronic phase">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>In the past, antimetabolites (e.g., <a href="/wiki/Cytarabine" title="Cytarabine">cytarabine</a>, <a href="/wiki/Hydroxyurea" title="Hydroxyurea" class="mw-redirect">hydroxyurea</a>), <a href="/wiki/Alkylating_antineoplastic_agent" title="Alkylating antineoplastic agent">alkylating agents</a>, <a href="/wiki/Interferon" title="Interferon">interferon alfa 2b</a>, and <a href="/wiki/Steroid" title="Steroid">steroids</a> were used as treatments of CML in the chronic phase, but since the 2000s have been replaced by <a href="/wiki/Bcr-Abl_tyrosine-kinase_inhibitor" title="Bcr-Abl tyrosine-kinase inhibitor">Bcr-Abl tyrosine-kinase inhibitors</a><sup id="cite_ref-CancerMedicine_15-0" class="reference"><a href="#cite_note-CancerMedicine-15"><span>[</span>15<span>]</span></a></sup> drugs that specifically target BCR-ABL, the constitutively activated tyrosine kinase fusion protein caused by the <a href="/wiki/Philadelphia_chromosome" title="Philadelphia chromosome">Philadelphia chromosome</a> translocation. Despite the move to replacing cytotoxic antineoplastics (standard anticancer drugs) with tyrosine kinase inhibitors sometimes hydroxyurea is still used to counteract the high WBCs encountered during treatment with tyrosine kinase inhibitors like imatinib; in these situations it may be the preferred myelosuppressive agent due to its relative lack of leukemogenic effects and hence the relative lack of potential for secondary haematologic malignancies to result from treatment.<sup id="cite_ref-MMSR_16-0" class="reference"><a href="#cite_note-MMSR-16"><span>[</span>16<span>]</span></a></sup> IRIS, an international study that compared interferon/cytarabine combination and the first of these new drugs imatinib, with long-term follow up, demonstrated the clear superiority of tyrosine-kinase-targeted inhibition over existing treatments.<sup id="cite_ref-17" class="reference"><a href="#cite_note-17"><span>[</span>17<span>]</span></a></sup></p>
<h4><span class="mw-headline" id="Imatinib">Imatinib</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Chronic_myelogenous_leukemia&amp;action=edit&amp;section=12" title="Edit section: Imatinib">edit</a><span class="mw-editsection-bracket">]</span></span></h4>
<p>The first of this new class of drugs was <a href="/wiki/Imatinib" title="Imatinib">imatinib mesylate</a> (marketed as Gleevec or Glivec), approved by the U.S. <a href="/wiki/Food_and_Drug_Administration" title="Food and Drug Administration">Food and Drug Administration</a> (FDA) in 2001. Imatinib was found to inhibit the progression of CML in the majority of patients (65–75%) sufficiently to achieve regrowth of their normal bone marrow stem cell population (a cytogenetic response) with stable proportions of maturing white blood cells. Because some leukemic cells (as evaluated by <a href="/wiki/RT-PCR" title="RT-PCR" class="mw-redirect">RT-PCR</a>) persist in nearly all patients, the treatment has to be continued indefinitely. Since the advent of imatinib, CML has become the first cancer in which a standard medical treatment may give to the patient a normal life expectancy.<sup id="cite_ref-GambacortiPasserini2011_18-0" class="reference"><a href="#cite_note-GambacortiPasserini2011-18"><span>[</span>18<span>]</span></a></sup></p>
<h4><span class="mw-headline" id="Dasatinib.2C_nilotinib_and_radotinib">Dasatinib, nilotinib and radotinib</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Chronic_myelogenous_leukemia&amp;action=edit&amp;section=13" title="Edit section: Dasatinib, nilotinib and radotinib">edit</a><span class="mw-editsection-bracket">]</span></span></h4>
<p>To overcome imatinib resistance and to increase responsiveness to TK inhibitors, three novel agents were later developed. The first, <a href="/wiki/Dasatinib" title="Dasatinib">dasatinib</a>, blocks several further oncogenic proteins, in addition to more potent inhibition of the BCR-ABL protein, and was initially approved in 2007 by the US FDA to treat CML in patients who were either resistant to or intolerant of imatinib. A second new TK inhibitor, <a href="/wiki/Nilotinib" title="Nilotinib">nilotinib</a>, was also approved by the FDA for the same indication. In 2012, <a href="/wiki/Radotinib" title="Radotinib">Radotinib</a> joined the class of novel agents in the inhibition of the BCR-ABL protein and was approved in South Korea for patients resistant to or intolerant of imatinib. In 2010, nilotinib and dasatinib were also approved for first-line therapy, making three drugs in this class available for treatment of newly diagnosed CML.</p>
<h4><span class="mw-headline" id="Treatment-resistant_CML">Treatment-resistant CML</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Chronic_myelogenous_leukemia&amp;action=edit&amp;section=14" title="Edit section: Treatment-resistant CML">edit</a><span class="mw-editsection-bracket">]</span></span></h4>
<p>While capable of producing significantly improved responses compared with the action of imatinib, neither dasatinib nor nilotinib could overcome drug resistance caused by one particular mutation found to occur in the structure of BCR-ABL known as the T315I mutation. Two approaches were developed to the treatment of CML as a result.</p>
<p>In 2007, <a href="/wiki/Cephalon#chemgenex" title="Cephalon">Chemgenex</a> released results of an open-label Phase 2/3 study (CGX-635-CML-202) that investigated the use of a non BCR-ABL targeted agent <a href="/wiki/Omacetaxine" title="Omacetaxine" class="mw-redirect">omacetaxine</a>, administered subcutaneously (under the skin) in patients who had failed with imatinib and exhibited T315I kinase domain mutation.<sup id="cite_ref-Jabbour_19-0" class="reference"><a href="#cite_note-Jabbour-19"><span>[</span>19<span>]</span></a></sup><sup id="cite_ref-Kimura2006_20-0" class="reference"><a href="#cite_note-Kimura2006-20"><span>[</span>20<span>]</span></a></sup> This is a study which is ongoing through 2014.<sup id="cite_ref-21" class="reference"><a href="#cite_note-21"><span>[</span>21<span>]</span></a></sup> In September 2012, the FDA approved omacetaxine for the treatment of CML in the case of resistance to other chemotherapeutic agents.<sup id="cite_ref-FDA27Oct2012_22-0" class="reference"><a href="#cite_note-FDA27Oct2012-22"><span>[</span>22<span>]</span></a></sup><sup id="cite_ref-23" class="reference"><a href="#cite_note-23"><span>[</span>23<span>]</span></a></sup></p>
<p>Independently, ARIAD pharmaceuticals, adapting the chemical structures from first and second-generation TK inhibitors, arrived at a new pan-BCR-ABL inhibitor which showed (for the first time) efficacy against T315I, as well as all other known mutations of the oncoprotein. The drug, <a href="/wiki/Ponatinib" title="Ponatinib">Ponatinib</a>, gained FDA approval in December 2012 for treatment of patients with resistant or intolerant CML. Just as with second generation TK inhibitors, early approval is being sought to extend the use of Ponatinib to newly diagnosed CML also.<sup class="noprint Inline-Template Template-Fact" style="white-space:nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed"><span title="This claim needs references to reliable sources. (December 2012)">citation needed</span></a></i>]</sup></p>
<p>Due to the high median age of patients with CML it is relatively rare for CML to be seen in pregnant women, despite this, however, chronic myelogenous leukemia can be treated with relative safety at any time during pregnancy with <a href="/wiki/Interferon-alpha" title="Interferon-alpha" class="mw-redirect">Interferon-alpha</a> hormones.<sup id="cite_ref-Shapira_24-0" class="reference"><a href="#cite_note-Shapira-24"><span>[</span>24<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Vaccination">Vaccination</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Chronic_myelogenous_leukemia&amp;action=edit&amp;section=15" title="Edit section: Vaccination">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>In 2005, encouraging but mixed results of <a href="/wiki/Vaccination" title="Vaccination">vaccination</a> were reported with the <i>BCR/abl</i> p210 fusion protein in patients with stable disease, with <a href="/wiki/GM-CSF" title="GM-CSF" class="mw-redirect">GM-CSF</a> as an adjuvant.<sup id="cite_ref-Bocchia2005_25-0" class="reference"><a href="#cite_note-Bocchia2005-25"><span>[</span>25<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Prognosis">Prognosis</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Chronic_myelogenous_leukemia&amp;action=edit&amp;section=16" title="Edit section: Prognosis">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>Before the advent of tyrosine kinase inhibitors, the median survival time for CML patients had been about 3–5 years from time of diagnosis.<sup id="cite_ref-MSR_1-1" class="reference"><a href="#cite_note-MSR-1"><span>[</span>1<span>]</span></a></sup></p>
<p>With the use of tyrosine kinase inhibitors, survival rates have improved dramatically. A 2006 followup of 553 patients using imatinib (Gleevic) found an overall survival rate of 89% after five years.<sup id="cite_ref-26" class="reference"><a href="#cite_note-26"><span>[</span>26<span>]</span></a></sup></p>
<p>A 2011 followup of 832 patients using imatinib who achieved a stable cytogenetic response found an overall survival rate of 95.2% after 8 years, which is similar to the rate in the general population. Less than 1% of patients died because of leukemia progression.<sup id="cite_ref-GambacortiPasserini2011_18-1" class="reference"><a href="#cite_note-GambacortiPasserini2011-18"><span>[</span>18<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Epidemiology">Epidemiology</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Chronic_myelogenous_leukemia&amp;action=edit&amp;section=17" title="Edit section: Epidemiology">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<h3><span class="mw-headline" id="UK">UK</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Chronic_myelogenous_leukemia&amp;action=edit&amp;section=18" title="Edit section: UK">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>CML accounts for 8% of all leukaemias in the UK, and around 680 people were diagnosed with the disease in 2011.<sup id="cite_ref-27" class="reference"><a href="#cite_note-27"><span>[</span>27<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="US">US</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Chronic_myelogenous_leukemia&amp;action=edit&amp;section=19" title="Edit section: US">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>The American Cancer Society estimates that in 2014, about 5,980 new cases of chronic myelogenous leukemia were diagnosed, and about 810 people died of the disease. This means that a little over 10% of all newly diagnosed leukemia cases will be chronic myelogenous leukemia. The average risk of a person getting this disease is 1 in 588. The disease is more common in men than women, and more common in whites than African-Americans. The average age at diagnosis is 64 years, and this disease is rarely seen in children.<sup id="cite_ref-28" class="reference"><a href="#cite_note-28"><span>[</span>28<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="References">References</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Chronic_myelogenous_leukemia&amp;action=edit&amp;section=20" title="Edit section: References">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<div class="reflist columns references-column-width" style="-moz-column-width: 33em; -webkit-column-width: 33em; column-width: 33em; list-style-type: decimal;">
<ol class="references">
<li id="cite_note-MSR-1"><span class="mw-cite-backlink">^ <a href="#cite_ref-MSR_1-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-MSR_1-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation web">Besa, EC; Buehler, B; Markman, M; Sacher, RA (27 December 2013). Krishnan, K, ed. <a rel="nofollow" class="external text" href="http://emedicine.medscape.com/article/199425-overview#showall">"Chronic Myelogenous Leukemia"</a>. <i>Medscape Reference</i>. WebMD<span class="reference-accessdate">. Retrieved <span class="nowrap">3 January</span> 2014</span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AChronic+myelogenous+leukemia&amp;rft.atitle=Chronic+Myelogenous+Leukemia&amp;rft.au=Besa%2C+EC%3B+Buehler%2C+B%3B+Markman%2C+M%3B+Sacher%2C+RA&amp;rft.aulast=Besa%2C+EC%3B+Buehler%2C+B%3B+Markman%2C+M%3B+Sacher%2C+RA&amp;rft.date=27+December+2013&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Femedicine.medscape.com%2Farticle%2F199425-overview%23showall&amp;rft.jtitle=Medscape+Reference&amp;rft.pub=WebMD&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-PMSR-2"><span class="mw-cite-backlink">^ <a href="#cite_ref-PMSR_2-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-PMSR_2-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-PMSR_2-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-PMSR_2-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-PMSR_2-4"><sup><i><b>e</b></i></sup></a></span> <span class="reference-text"><span class="citation web">Besa, EC; Buehler, B; Markman, M; Sacher, RA (27 December 2013). Krishnan, K, ed. <a rel="nofollow" class="external text" href="http://emedicine.medscape.com/article/199425-clinical#showall">"Chronic Myelogenous Leukemia Clinical Presentation"</a>. <i>Medscape Reference</i>. WebMD<span class="reference-accessdate">. Retrieved <span class="nowrap">3 January</span> 2014</span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AChronic+myelogenous+leukemia&amp;rft.atitle=Chronic+Myelogenous+Leukemia+Clinical+Presentation&amp;rft.au=Besa%2C+EC%3B+Buehler%2C+B%3B+Markman%2C+M%3B+Sacher%2C+RA&amp;rft.aulast=Besa%2C+EC%3B+Buehler%2C+B%3B+Markman%2C+M%3B+Sacher%2C+RA&amp;rft.date=27+December+2013&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Femedicine.medscape.com%2Farticle%2F199425-clinical%23showall&amp;rft.jtitle=Medscape+Reference&amp;rft.pub=WebMD&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-MolHem-3"><span class="mw-cite-backlink">^ <a href="#cite_ref-MolHem_3-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-MolHem_3-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-MolHem_3-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-MolHem_3-3"><sup><i><b>d</b></i></sup></a></span> <span class="reference-text"><span class="citation book">Provan, D; Gribben, JG (2010). "Chapter 7 Chronic myelogenous leukemia". <a rel="nofollow" class="external text" href="https://books.google.com/?id=u0fIkvX9BdYC&amp;pg=PA76&amp;dq=%22chronic+myelogenous+leukemia%22+#v=onepage&amp;q&amp;f=true"><i>Molecular Hematology</i></a> (3rd ed.). Singapore: Wiley-Blackwell. p.&#160;76. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a>&#160;<a href="/wiki/Special:BookSources/9781444318548" title="Special:BookSources/9781444318548">9781444318548</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AChronic+myelogenous+leukemia&amp;rft.atitle=Chapter+7+Chronic+myelogenous+leukemia&amp;rft.aulast=Provan%2C+D%3B+Gribben%2C+JG&amp;rft.au=Provan%2C+D%3B+Gribben%2C+JG&amp;rft.btitle=Molecular+Hematology&amp;rft.date=2010&amp;rft.edition=3rd&amp;rft.genre=bookitem&amp;rft_id=https%3A%2F%2Fbooks.google.com%2F%3Fid%3Du0fIkvX9BdYC%26pg%3DPA76%26dq%3D%2522chronic%2Bmyelogenous%2Bleukemia%2522%2B%23v%3Donepage%26q%26f%3Dtrue&amp;rft.isbn=9781444318548&amp;rft.pages=76&amp;rft.place=Singapore&amp;rft.pub=Wiley-Blackwell&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Tefferi-4"><span class="mw-cite-backlink">^ <a href="#cite_ref-Tefferi_4-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Tefferi_4-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Tefferi_4-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Tefferi_4-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-Tefferi_4-4"><sup><i><b>e</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Tefferi A (2006). "Classification, diagnosis and management of myeloproliferative disorders in the JAK2V617F era". <i>Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program</i> <b>2006</b>: 240–5. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1182%2Fasheducation-2006.1.240">10.1182/asheducation-2006.1.240</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/17124067">17124067</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AChronic+myelogenous+leukemia&amp;rft.atitle=Classification%2C+diagnosis+and+management+of+myeloproliferative+disorders+in+the+JAK2V617F+era&amp;rft.aulast=Tefferi+A&amp;rft.au=Tefferi+A&amp;rft.date=2006&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1182%2Fasheducation-2006.1.240&amp;rft_id=info%3Apmid%2F17124067&amp;rft.jtitle=Hematology+%2F+the+Education+Program+of+the+American+Society+of+Hematology.+American+Society+of+Hematology.+Education+Program&amp;rft.pages=240-5&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=2006" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-5"><span class="mw-cite-backlink"><b><a href="#cite_ref-5">^</a></b></span> <span class="reference-text"><span class="citation journal">Savage DG, Szydlo RM, Goldman JM (Jan 1997). "Clinical features at diagnosis in 430 patients with chronic myeloid leukaemia seen at a referral centre over a 16-year period". <i>British Journal of Haematology</i> <b>96</b> (1): 111–6. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1046%2Fj.1365-2141.1997.d01-1982.x">10.1046/j.1365-2141.1997.d01-1982.x</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/9012696">9012696</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AChronic+myelogenous+leukemia&amp;rft.atitle=Clinical+features+at+diagnosis+in+430+patients+with+chronic+myeloid+leukaemia+seen+at+a+referral+centre+over+a+16-year+period&amp;rft.aulast=Savage+DG%2C+Szydlo+RM%2C+Goldman+JM&amp;rft.au=Savage+DG%2C+Szydlo+RM%2C+Goldman+JM&amp;rft.date=Jan+1997&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1046%2Fj.1365-2141.1997.d01-1982.x&amp;rft_id=info%3Apmid%2F9012696&amp;rft.issue=1&amp;rft.jtitle=British+Journal+of+Haematology&amp;rft.pages=111-6&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=96" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-WHO-6"><span class="mw-cite-backlink">^ <a href="#cite_ref-WHO_6-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-WHO_6-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-WHO_6-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Tefferi A, Thiele J, Orazi A, Kvasnicka HM, Barbui T, Hanson CA, Barosi G, Verstovsek S, Birgegard G, Mesa R, Reilly JT, Gisslinger H, Vannucchi AM, Cervantes F, Finazzi G, Hoffman R, Gilliland DG, Bloomfield CD, Vardiman JW (Aug 2007). "Proposals and rationale for revision of the World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis: recommendations from an ad hoc international expert panel". <i>Blood</i> <b>110</b> (4): 1092–7. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1182%2Fblood-2007-04-083501">10.1182/blood-2007-04-083501</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/17488875">17488875</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AChronic+myelogenous+leukemia&amp;rft.atitle=Proposals+and+rationale+for+revision+of+the+World+Health+Organization+diagnostic+criteria+for+polycythemia+vera%2C+essential+thrombocythemia%2C+and+primary+myelofibrosis%3A+recommendations+from+an+ad+hoc+international+expert+panel&amp;rft.aulast=Tefferi+A%2C+Thiele+J%2C+Orazi+A%2C+Kvasnicka+HM%2C+Barbui+T%2C+Hanson+CA%2C+Barosi+G%2C+Verstovsek+S%2C+Birgegard+G%2C+Mesa+R%2C+Reilly+JT%2C+Gisslinger+H%2C+Vannucchi+AM%2C+Cervantes+F%2C+Finazzi+G%2C+Hoffman+R%2C+Gilliland+DG%2C+Bloomfield+CD%2C+Vardiman+JW&amp;rft.au=Tefferi+A%2C+Thiele+J%2C+Orazi+A%2C+Kvasnicka+HM%2C+Barbui+T%2C+Hanson+CA%2C+Barosi+G%2C+Verstovsek+S%2C+Birgegard+G%2C+Mesa+R%2C+Reilly+JT%2C+Gisslinger+H%2C+Vannucchi+AM%2C+Cervantes+F%2C+Finazzi+G%2C+Hoffman+R%2C+Gilliland+DG%2C+Bloomfield+CD%2C+Vardiman+JW&amp;rft.date=Aug+2007&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1182%2Fblood-2007-04-083501&amp;rft_id=info%3Apmid%2F17488875&amp;rft.issue=4&amp;rft.jtitle=Blood&amp;rft.pages=1092-7&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=110" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-7"><span class="mw-cite-backlink"><b><a href="#cite_ref-7">^</a></b></span> <span class="reference-text"><span class="citation journal">Nowell PC (Aug 2007). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC1934591">"Discovery of the Philadelphia chromosome: a personal perspective"</a>. <i>The Journal of Clinical Investigation</i> <b>117</b> (8): 2033–5. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1172%2FJCI31771">10.1172/JCI31771</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC1934591">1934591</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/17671636">17671636</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AChronic+myelogenous+leukemia&amp;rft.atitle=Discovery+of+the+Philadelphia+chromosome%3A+a+personal+perspective&amp;rft.aulast=Nowell+PC&amp;rft.au=Nowell+PC&amp;rft.date=Aug+2007&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1934591&amp;rft_id=info%3Adoi%2F10.1172%2FJCI31771&amp;rft_id=info%3Apmc%2F1934591&amp;rft_id=info%3Apmid%2F17671636&amp;rft.issue=8&amp;rft.jtitle=The+Journal+of+Clinical+Investigation&amp;rft.pages=2033-5&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=117" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Faderl1990-8"><span class="mw-cite-backlink">^ <a href="#cite_ref-Faderl1990_8-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Faderl1990_8-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Faderl S, Talpaz M, Estrov Z, Kantarjian HM (Aug 1999). "Chronic myelogenous leukemia: biology and therapy". <i>Annals of Internal Medicine</i> <b>131</b> (3): 207–219. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.7326%2F0003-4819-131-3-199908030-00008">10.7326/0003-4819-131-3-199908030-00008</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/10428738">10428738</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AChronic+myelogenous+leukemia&amp;rft.atitle=Chronic+myelogenous+leukemia%3A+biology+and+therapy&amp;rft.au=Faderl+S%2C+Talpaz+M%2C+Estrov+Z%2C+Kantarjian+HM&amp;rft.aulast=Faderl+S%2C+Talpaz+M%2C+Estrov+Z%2C+Kantarjian+HM&amp;rft.date=Aug+1999&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.7326%2F0003-4819-131-3-199908030-00008&amp;rft_id=info%3Apmid%2F10428738&amp;rft.issue=3&amp;rft.jtitle=Annals+of+Internal+Medicine&amp;rft.pages=207-219&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=131" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Hehlmann-9"><span class="mw-cite-backlink">^ <a href="#cite_ref-Hehlmann_9-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Hehlmann_9-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Hehlmann R, Hochhaus A, Baccarani M (Jul 2007). "Chronic myeloid leukaemia". <i>Lancet</i> <b>370</b> (9584): 342–50. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2FS0140-6736%2807%2961165-9">10.1016/S0140-6736(07)61165-9</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/17662883">17662883</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AChronic+myelogenous+leukemia&amp;rft.atitle=Chronic+myeloid+leukaemia&amp;rft.au=Hehlmann+R%2C+Hochhaus+A%2C+Baccarani+M&amp;rft.aulast=Hehlmann+R%2C+Hochhaus+A%2C+Baccarani+M&amp;rft.date=Jul+2007&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2FS0140-6736%2807%2961165-9&amp;rft_id=info%3Apmid%2F17662883&amp;rft.issue=9584&amp;rft.jtitle=Lancet&amp;rft.pages=342-50&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=370" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-10"><span class="mw-cite-backlink"><b><a href="#cite_ref-10">^</a></b></span> <span class="reference-text"><span class="citation journal">Kantarjian HM, Dixon D, Keating MJ, Talpaz M, Walters RS, McCredie KB, Freireich EJ (Apr 1988). "Characteristics of accelerated disease in chronic myelogenous leukemia". <i>Cancer</i> <b>61</b> (7): 1441–6. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1002%2F1097-0142%2819880401%2961%3A7%3C1441%3A%3AAID-CNCR2820610727%3E3.0.CO%3B2-C">10.1002/1097-0142(19880401)61:7&lt;1441::AID-CNCR2820610727&gt;3.0.CO;2-C</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/3162181">3162181</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AChronic+myelogenous+leukemia&amp;rft.atitle=Characteristics+of+accelerated+disease+in+chronic+myelogenous+leukemia&amp;rft.au=Kantarjian+HM%2C+Dixon+D%2C+Keating+MJ%2C+Talpaz+M%2C+Walters+RS%2C+McCredie+KB%2C+Freireich+EJ&amp;rft.aulast=Kantarjian+HM%2C+Dixon+D%2C+Keating+MJ%2C+Talpaz+M%2C+Walters+RS%2C+McCredie+KB%2C+Freireich+EJ&amp;rft.date=Apr+1988&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1002%2F1097-0142%2819880401%2961%3A7%3C1441%3A%3AAID-CNCR2820610727%3E3.0.CO%3B2-C&amp;rft_id=info%3Apmid%2F3162181&amp;rft.issue=7&amp;rft.jtitle=Cancer&amp;rft.pages=1441-6&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=61" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-11"><span class="mw-cite-backlink"><b><a href="#cite_ref-11">^</a></b></span> <span class="reference-text"><span class="citation journal">Sokal JE, Baccarani M, Russo D, Tura S (Jan 1988). "Staging and prognosis in chronic myelogenous leukemia". <i>Seminars in Hematology</i> <b>25</b> (1): 49–61. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/3279515">3279515</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AChronic+myelogenous+leukemia&amp;rft.atitle=Staging+and+prognosis+in+chronic+myelogenous+leukemia&amp;rft.aulast=Sokal+JE%2C+Baccarani+M%2C+Russo+D%2C+Tura+S&amp;rft.au=Sokal+JE%2C+Baccarani+M%2C+Russo+D%2C+Tura+S&amp;rft.date=Jan+1988&amp;rft.genre=article&amp;rft_id=info%3Apmid%2F3279515&amp;rft.issue=1&amp;rft.jtitle=Seminars+in+Hematology&amp;rft.pages=49-61&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=25" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-12"><span class="mw-cite-backlink"><b><a href="#cite_ref-12">^</a></b></span> <span class="reference-text"><span class="citation journal">Vardiman JW, Harris NL, Brunning RD (Oct 2002). <a rel="nofollow" class="external text" href="http://www.bloodjournal.org/cgi/content/full/100/7/2292">"The World Health Organization (WHO) classification of the myeloid neoplasms"</a>. <i>Blood</i> <b>100</b> (7): 2292–302. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1182%2Fblood-2002-04-1199">10.1182/blood-2002-04-1199</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/12239137">12239137</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AChronic+myelogenous+leukemia&amp;rft.atitle=The+World+Health+Organization+%28WHO%29+classification+of+the+myeloid+neoplasms&amp;rft.aulast=Vardiman+JW%2C+Harris+NL%2C+Brunning+RD&amp;rft.au=Vardiman+JW%2C+Harris+NL%2C+Brunning+RD&amp;rft.date=Oct+2002&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.bloodjournal.org%2Fcgi%2Fcontent%2Ffull%2F100%2F7%2F2292&amp;rft_id=info%3Adoi%2F10.1182%2Fblood-2002-04-1199&amp;rft_id=info%3Apmid%2F12239137&amp;rft.issue=7&amp;rft.jtitle=Blood&amp;rft.pages=2292-302&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=100" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-13"><span class="mw-cite-backlink"><b><a href="#cite_ref-13">^</a></b></span> <span class="reference-text"><span class="citation journal">Karbasian Esfahani M, Morris EL, Dutcher JP, Wiernik PH (May 2006). "Blastic phase of chronic myelogenous leukemia". <i>Current Treatment Options in Oncology</i> <b>7</b> (3): 189–199. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1007%2Fs11864-006-0012-y">10.1007/s11864-006-0012-y</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/16615875">16615875</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AChronic+myelogenous+leukemia&amp;rft.atitle=Blastic+phase+of+chronic+myelogenous+leukemia&amp;rft.au=Karbasian+Esfahani+M%2C+Morris+EL%2C+Dutcher+JP%2C+Wiernik+PH&amp;rft.aulast=Karbasian+Esfahani+M%2C+Morris+EL%2C+Dutcher+JP%2C+Wiernik+PH&amp;rft.date=May+2006&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1007%2Fs11864-006-0012-y&amp;rft_id=info%3Apmid%2F16615875&amp;rft.issue=3&amp;rft.jtitle=Current+Treatment+Options+in+Oncology&amp;rft.pages=189-199&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=7" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-TMSR-14"><span class="mw-cite-backlink">^ <a href="#cite_ref-TMSR_14-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-TMSR_14-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation web">Besa, EC; Buehler, B; Markman, M; Sacher, RA (27 December 2013). Krishnan, K, ed. <a rel="nofollow" class="external text" href="http://emedicine.medscape.com/article/199425-treatment#showall">"Chronic Myelogenous Leukemia Treatment &amp; Management"</a>. <i>Medscape Reference</i>. WebMD<span class="reference-accessdate">. Retrieved <span class="nowrap">4 January</span> 2014</span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AChronic+myelogenous+leukemia&amp;rft.atitle=Chronic+Myelogenous+Leukemia+Treatment+%26+Management&amp;rft.au=Besa%2C+EC%3B+Buehler%2C+B%3B+Markman%2C+M%3B+Sacher%2C+RA&amp;rft.aulast=Besa%2C+EC%3B+Buehler%2C+B%3B+Markman%2C+M%3B+Sacher%2C+RA&amp;rft.date=27+December+2013&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Femedicine.medscape.com%2Farticle%2F199425-treatment%23showall&amp;rft.jtitle=Medscape+Reference&amp;rft.pub=WebMD&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-CancerMedicine-15"><span class="mw-cite-backlink"><b><a href="#cite_ref-CancerMedicine_15-0">^</a></b></span> <span class="reference-text"><span class="citation book">Kufe DW; Pollack RE; Weichselbau RR et al., eds. (2003). "Tyrosine Kinase Inhibitors: Targeting Considerations". <a rel="nofollow" class="external text" href="http://www.ncbi.nlm.nih.gov/books/NBK13641/"><i>Holland-Frei Cancer Medicine</i></a> (<a href="/wiki/NCBI_bookshelf" title="NCBI bookshelf" class="mw-redirect">NCBI bookshelf</a> book) (6th ed.). <a href="/wiki/Hamilton,_Ontario" title="Hamilton, Ontario">Hamilton, Ontario</a>: <a href="/w/index.php?title=BC_Decker&amp;action=edit&amp;redlink=1" class="new" title="BC Decker (page does not exist)">BC Decker</a>. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a>&#160;<a href="/wiki/Special:BookSources/1-55009-213-8" title="Special:BookSources/1-55009-213-8">1-55009-213-8</a><span class="reference-accessdate">. Retrieved <span class="nowrap">October 27,</span> 2012</span></span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AChronic+myelogenous+leukemia&amp;rft.atitle=Tyrosine+Kinase+Inhibitors%3A+Targeting+Considerations&amp;rft.btitle=Holland-Frei+Cancer+Medicine&amp;rft.date=2003&amp;rft.edition=6th&amp;rft.genre=bookitem&amp;rft_id=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK13641%2F&amp;rft.isbn=1-55009-213-8&amp;rft.place=Hamilton%2C+Ontario&amp;rft.pub=BC+Decker&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-MMSR-16"><span class="mw-cite-backlink"><b><a href="#cite_ref-MMSR_16-0">^</a></b></span> <span class="reference-text"><span class="citation web">Besa, EC; Buehler, B; Markman, M; Sacher, RA (27 December 2013). Krishnan, K, ed. <a rel="nofollow" class="external text" href="http://emedicine.medscape.com/article/199425-medication#showall">"Chronic Myelogenous Leukemia"</a>. <i>Medscape Reference</i>. WebMD<span class="reference-accessdate">. Retrieved <span class="nowrap">3 January</span> 2014</span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AChronic+myelogenous+leukemia&amp;rft.atitle=Chronic+Myelogenous+Leukemia&amp;rft.au=Besa%2C+EC%3B+Buehler%2C+B%3B+Markman%2C+M%3B+Sacher%2C+RA&amp;rft.aulast=Besa%2C+EC%3B+Buehler%2C+B%3B+Markman%2C+M%3B+Sacher%2C+RA&amp;rft.date=27+December+2013&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Femedicine.medscape.com%2Farticle%2F199425-medication%23showall&amp;rft.jtitle=Medscape+Reference&amp;rft.pub=WebMD&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-17"><span class="mw-cite-backlink"><b><a href="#cite_ref-17">^</a></b></span> <span class="reference-text"><span class="citation journal">DeAngelo DJ, Ritz J (Jan 2004). <a rel="nofollow" class="external text" href="http://clincancerres.aacrjournals.org/content/10/1/1.full.pdf">"Imatinib therapy for patients with chronic myelogenous leukemia: are patients living longer?"</a> <span style="font-size:85%;">(PDF)</span>. <i>Clinical Cancer Research&#160;: An Official Journal of the American Association for Cancer Research</i> <b>10</b> (1 Pt 1): 1–3. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1158%2F1078-0432.CCR-1218-3">10.1158/1078-0432.CCR-1218-3</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/14734443">14734443</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AChronic+myelogenous+leukemia&amp;rft.atitle=Imatinib+therapy+for+patients+with+chronic+myelogenous+leukemia%3A+are+patients+living+longer%3F&amp;rft.au=DeAngelo+DJ%2C+Ritz+J&amp;rft.aulast=DeAngelo+DJ%2C+Ritz+J&amp;rft.date=Jan+2004&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fclincancerres.aacrjournals.org%2Fcontent%2F10%2F1%2F1.full.pdf&amp;rft_id=info%3Adoi%2F10.1158%2F1078-0432.CCR-1218-3&amp;rft_id=info%3Apmid%2F14734443&amp;rft.issue=1+Pt+1&amp;rft.jtitle=Clinical+Cancer+Research+%3A+An+Official+Journal+of+the+American+Association+for+Cancer+Research&amp;rft.pages=1-3&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=10" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-GambacortiPasserini2011-18"><span class="mw-cite-backlink">^ <a href="#cite_ref-GambacortiPasserini2011_18-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-GambacortiPasserini2011_18-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Gambacorti-Passerini C, Antolini L, Mahon FX, Guilhot F, Deininger M, Fava C, Nagler A, Della Casa CM, Morra E, Abruzzese E, D'Emilio A, Stagno F, le Coutre P, Hurtado-Monroy R, Santini V, Martino B, Pane F, Piccin A, Giraldo P, Assouline S, Durosinmi MA, Leeksma O, Pogliani EM, Puttini M, Jang E, Reiffers J, Valsecchi MG, Kim DW (Apr 2011). "Multicenter independent assessment of outcomes in chronic myeloid leukemia patients treated with imatinib". <i>Journal of the National Cancer Institute</i> <b>103</b> (7): 553–561. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1093%2Fjnci%2Fdjr060">10.1093/jnci/djr060</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/21422402">21422402</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AChronic+myelogenous+leukemia&amp;rft.atitle=Multicenter+independent+assessment+of+outcomes+in+chronic+myeloid+leukemia+patients+treated+with+imatinib&amp;rft.au=Gambacorti-Passerini+C%2C+Antolini+L%2C+Mahon+FX%2C+Guilhot+F%2C+Deininger+M%2C+Fava+C%2C+Nagler+A%2C+Della+Casa+CM%2C+Morra+E%2C+Abruzzese+E%2C+D%27Emilio+A%2C+Stagno+F%2C+le+Coutre+P%2C+Hurtado-Monroy+R%2C+Santini+V%2C+Martino+B%2C+Pane+F%2C+Piccin+A%2C+Giraldo+P%2C+Assouline+S%2C+Durosinmi+MA%2C+Leeksma+O%2C+Pogliani+EM%2C+Puttini+M%2C+Jang+E%2C+Reiffers+J%2C+Valsecchi+MG%2C+Kim+DW&amp;rft.aulast=Gambacorti-Passerini+C%2C+Antolini+L%2C+Mahon+FX%2C+Guilhot+F%2C+Deininger+M%2C+Fava+C%2C+Nagler+A%2C+Della+Casa+CM%2C+Morra+E%2C+Abruzzese+E%2C+D%27Emilio+A%2C+Stagno+F%2C+le+Coutre+P%2C+Hurtado-Monroy+R%2C+Santini+V%2C+Martino+B%2C+Pane+F%2C+Piccin+A%2C+Giraldo+P%2C+Assouline+S%2C+Durosinmi+MA%2C+Leeksma+O%2C+Pogliani+EM%2C+Puttini+M%2C+Jang+E%2C+Reiffers+J%2C+Valsecchi+MG%2C+Kim+DW&amp;rft.date=Apr+2011&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1093%2Fjnci%2Fdjr060&amp;rft_id=info%3Apmid%2F21422402&amp;rft.issue=7&amp;rft.jtitle=Journal+of+the+National+Cancer+Institute&amp;rft.pages=553-561&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=103" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Jabbour-19"><span class="mw-cite-backlink"><b><a href="#cite_ref-Jabbour_19-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Jabbour E, Cortes JE, Giles FJ, O'Brien S, Kantarjian HM (Jun 2007). "Current and emerging treatment options in chronic myeloid leukemia". <i>Cancer</i> <b>109</b> (11): 2171–2181. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1002%2Fcncr.22661">10.1002/cncr.22661</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/17431887">17431887</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AChronic+myelogenous+leukemia&amp;rft.atitle=Current+and+emerging+treatment+options+in+chronic+myeloid+leukemia&amp;rft.au=Jabbour+E%2C+Cortes+JE%2C+Giles+FJ%2C+O%27Brien+S%2C+Kantarjian+HM&amp;rft.aulast=Jabbour+E%2C+Cortes+JE%2C+Giles+FJ%2C+O%27Brien+S%2C+Kantarjian+HM&amp;rft.date=Jun+2007&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1002%2Fcncr.22661&amp;rft_id=info%3Apmid%2F17431887&amp;rft.issue=11&amp;rft.jtitle=Cancer&amp;rft.pages=2171-2181&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=109" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Kimura2006-20"><span class="mw-cite-backlink"><b><a href="#cite_ref-Kimura2006_20-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Kimura S, Ashihara E, Maekawa T (Oct 2006). "New tyrosine kinase inhibitors in the treatment of chronic myeloid leukemia". <i>Current Pharmaceutical Biotechnology</i> <b>7</b> (5): 371–379. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.2174%2F138920106778521532">10.2174/138920106778521532</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/17076652">17076652</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AChronic+myelogenous+leukemia&amp;rft.atitle=New+tyrosine+kinase+inhibitors+in+the+treatment+of+chronic+myeloid+leukemia&amp;rft.au=Kimura+S%2C+Ashihara+E%2C+Maekawa+T&amp;rft.aulast=Kimura+S%2C+Ashihara+E%2C+Maekawa+T&amp;rft.date=Oct+2006&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.2174%2F138920106778521532&amp;rft_id=info%3Apmid%2F17076652&amp;rft.issue=5&amp;rft.jtitle=Current+Pharmaceutical+Biotechnology&amp;rft.pages=371-379&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=7" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-21"><span class="mw-cite-backlink"><b><a href="#cite_ref-21">^</a></b></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://clinicaltrials.gov/ct2/show/results/NCT00375219">"Homoharringtonine (Omacetaxine Mepesuccinate) in Treating Patients With Chronic Myeloid Leukemia (CML) With the T315I BCR-ABL Gene Mutation"</a>. <i>ClinicalTrial.gov</i> (database recprd)<span class="reference-accessdate">. Retrieved <span class="nowrap">October 27,</span> 2012</span></span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AChronic+myelogenous+leukemia&amp;rft.atitle=Homoharringtonine+%28Omacetaxine+Mepesuccinate%29+in+Treating+Patients+With+Chronic+Myeloid+Leukemia+%28CML%29+With+the+T315I+BCR-ABL+Gene+Mutation&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2Fresults%2FNCT00375219&amp;rft.jtitle=ClinicalTrial.gov&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-FDA27Oct2012-22"><span class="mw-cite-backlink"><b><a href="#cite_ref-FDA27Oct2012_22-0">^</a></b></span> <span class="reference-text"><span class="citation journal"><a rel="nofollow" class="external text" href="http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm325895.htm">"FDA approves Synribo for chronic myelogenous leukemia"</a> (press release). U.S. <a href="/wiki/Food_and_Drug_Administration" title="Food and Drug Administration">Food and Drug Administration</a>. October 26, 2012<span class="reference-accessdate">. Retrieved <span class="nowrap">October 27,</span> 2012</span></span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AChronic+myelogenous+leukemia&amp;rft.btitle=FDA+approves+Synribo+for+chronic+myelogenous+leukemia&amp;rft.date=October+26%2C+2012&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fwww.fda.gov%2FNewsEvents%2FNewsroom%2FPressAnnouncements%2Fucm325895.htm&amp;rft.pub=U.S.+Food+and+Drug+Administration&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-23"><span class="mw-cite-backlink"><b><a href="#cite_ref-23">^</a></b></span> <span class="reference-text"><span class="citation journal"><a rel="nofollow" class="external text" href="http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm318160.htm">"FDA approves new orphan drug for chronic myelogenous leukemia"</a> (press re;ease). U.S. <a href="/wiki/Food_and_Drug_Administration" title="Food and Drug Administration">Food and Drug Administration</a>. September 4, 2012<span class="reference-accessdate">. Retrieved <span class="nowrap">October 27,</span> 2012</span></span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AChronic+myelogenous+leukemia&amp;rft.btitle=FDA+approves+new+orphan+drug+for+chronic+myelogenous+leukemia&amp;rft.date=September+4%2C+2012&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fwww.fda.gov%2FNewsEvents%2FNewsroom%2FPressAnnouncements%2Fucm318160.htm&amp;rft.pub=U.S.+Food+and+Drug+Administration&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Shapira-24"><span class="mw-cite-backlink"><b><a href="#cite_ref-Shapira_24-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Shapira T, Pereg D, Lishner M (Sep 2008). "How I treat acute and chronic leukemia in pregnancy". <i>Blood Reviews</i> <b>22</b> (5): 247–59. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2Fj.blre.2008.03.006">10.1016/j.blre.2008.03.006</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/18472198">18472198</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AChronic+myelogenous+leukemia&amp;rft.atitle=How+I+treat+acute+and+chronic+leukemia+in+pregnancy&amp;rft.aulast=Shapira+T%2C+Pereg+D%2C+Lishner+M&amp;rft.au=Shapira+T%2C+Pereg+D%2C+Lishner+M&amp;rft.date=Sep+2008&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2Fj.blre.2008.03.006&amp;rft_id=info%3Apmid%2F18472198&amp;rft.issue=5&amp;rft.jtitle=Blood+Reviews&amp;rft.pages=247-59&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=22" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Bocchia2005-25"><span class="mw-cite-backlink"><b><a href="#cite_ref-Bocchia2005_25-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Bocchia M, Gentili S, Abruzzese E, Fanelli A, Iuliano F, Tabilio A, Amabile M, Forconi F, Gozzetti A, Raspadori D, Amadori S, Lauria F (2005). "Effect of a p210 multipeptide vaccine associated with imatinib or interferon in patients with chronic myeloid leukaemia and persistent residual disease: a multicentre observational trial". <i>Lancet</i> <b>365</b> (9460): 657–662. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2FS0140-6736%2805%2917945-8">10.1016/S0140-6736(05)17945-8</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/15721470">15721470</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AChronic+myelogenous+leukemia&amp;rft.atitle=Effect+of+a+p210+multipeptide+vaccine+associated+with+imatinib+or+interferon+in+patients+with+chronic+myeloid+leukaemia+and+persistent+residual+disease%3A+a+multicentre+observational+trial&amp;rft.au=Bocchia+M%2C+Gentili+S%2C+Abruzzese+E%2C+Fanelli+A%2C+Iuliano+F%2C+Tabilio+A%2C+Amabile+M%2C+Forconi+F%2C+Gozzetti+A%2C+Raspadori+D%2C+Amadori+S%2C+Lauria+F&amp;rft.aulast=Bocchia+M%2C+Gentili+S%2C+Abruzzese+E%2C+Fanelli+A%2C+Iuliano+F%2C+Tabilio+A%2C+Amabile+M%2C+Forconi+F%2C+Gozzetti+A%2C+Raspadori+D%2C+Amadori+S%2C+Lauria+F&amp;rft.date=2005&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2FS0140-6736%2805%2917945-8&amp;rft_id=info%3Apmid%2F15721470&amp;rft.issue=9460&amp;rft.jtitle=Lancet&amp;rft.pages=657-662&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=365" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-26"><span class="mw-cite-backlink"><b><a href="#cite_ref-26">^</a></b></span> <span class="reference-text"><span class="citation journal">Druker BJ, Guilhot F, O'Brien SG, Gathmann I, Kantarjian H, Gattermann N, Deininger MW, Silver RT, Goldman JM, Stone RM, Cervantes F, Hochhaus A, Powell BL, Gabrilove JL, Rousselot P, Reiffers J, Cornelissen JJ, Hughes T, Agis H, Fischer T, Verhoef G, Shepherd J, Saglio G, Gratwohl A, Nielsen JL, Radich JP, Simonsson B, Taylor K, Baccarani M, So C, Letvak L, Larson RA (Dec 2006). <a rel="nofollow" class="external text" href="http://content.nejm.org/cgi/content/full/355/23/2408">"Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia"</a>. <i>The New England Journal of Medicine</i> <b>355</b> (23): 2408–17. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1056%2FNEJMoa062867">10.1056/NEJMoa062867</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/17151364">17151364</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AChronic+myelogenous+leukemia&amp;rft.atitle=Five-year+follow-up+of+patients+receiving+imatinib+for+chronic+myeloid+leukemia&amp;rft.au=Druker+BJ%2C+Guilhot+F%2C+O%27Brien+SG%2C+Gathmann+I%2C+Kantarjian+H%2C+Gattermann+N%2C+Deininger+MW%2C+Silver+RT%2C+Goldman+JM%2C+Stone+RM%2C+Cervantes+F%2C+Hochhaus+A%2C+Powell+BL%2C+Gabrilove+JL%2C+Rousselot+P%2C+Reiffers+J%2C+Cornelissen+JJ%2C+Hughes+T%2C+Agis+H%2C+Fischer+T%2C+Verhoef+G%2C+Shepherd+J%2C+Saglio+G%2C+Gratwohl+A%2C+Nielsen+JL%2C+Radich+JP%2C+Simonsson+B%2C+Taylor+K%2C+Baccarani+M%2C+So+C%2C+Letvak+L%2C+Larson+RA&amp;rft.aulast=Druker+BJ%2C+Guilhot+F%2C+O%27Brien+SG%2C+Gathmann+I%2C+Kantarjian+H%2C+Gattermann+N%2C+Deininger+MW%2C+Silver+RT%2C+Goldman+JM%2C+Stone+RM%2C+Cervantes+F%2C+Hochhaus+A%2C+Powell+BL%2C+Gabrilove+JL%2C+Rousselot+P%2C+Reiffers+J%2C+Cornelissen+JJ%2C+Hughes+T%2C+Agis+H%2C+Fischer+T%2C+Verhoef+G%2C+Shepherd+J%2C+Saglio+G%2C+Gratwohl+A%2C+Nielsen+JL%2C+Radich+JP%2C+Simonsson+B%2C+Taylor+K%2C+Baccarani+M%2C+So+C%2C+Letvak+L%2C+Larson+RA&amp;rft.date=Dec+2006&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fcontent.nejm.org%2Fcgi%2Fcontent%2Ffull%2F355%2F23%2F2408&amp;rft_id=info%3Adoi%2F10.1056%2FNEJMoa062867&amp;rft_id=info%3Apmid%2F17151364&amp;rft.issue=23&amp;rft.jtitle=The+New+England+Journal+of+Medicine&amp;rft.pages=2408-17&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=355" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-27"><span class="mw-cite-backlink"><b><a href="#cite_ref-27">^</a></b></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://www.cancerresearchuk.org/cancer-info/cancerstats/types/leukaemia-cml/">"Chronic myeloid leukaemia (CML) statistics"</a>. <i>Cancer Research UK</i><span class="reference-accessdate">. Retrieved <span class="nowrap">28 October</span> 2014</span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AChronic+myelogenous+leukemia&amp;rft.atitle=Chronic+myeloid+leukaemia+%28CML%29+statistics&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.cancerresearchuk.org%2Fcancer-info%2Fcancerstats%2Ftypes%2Fleukaemia-cml%2F&amp;rft.jtitle=Cancer+Research+UK&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-28"><span class="mw-cite-backlink"><b><a href="#cite_ref-28">^</a></b></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://www.cancer.org/cancer/leukemia-chronicmyeloidcml/detailedguide/leukemia-chronic-myeloid-myelogenous-key-statistics">"What are the key statistics about chronic myeloid leukemia?"</a>. <i>www.cancer.org</i>. American Cancer Society<span class="reference-accessdate">. Retrieved <span class="nowrap">6 January</span> 2015</span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AChronic+myelogenous+leukemia&amp;rft.atitle=What+are+the+key+statistics+about+chronic+myeloid+leukemia%3F&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.cancer.org%2Fcancer%2Fleukemia-chronicmyeloidcml%2Fdetailedguide%2Fleukemia-chronic-myeloid-myelogenous-key-statistics&amp;rft.jtitle=www.cancer.org&amp;rft.pub=American+Cancer+Society&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
</ol>
</div>
<h2><span class="mw-headline" id="External_links">External links</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Chronic_myelogenous_leukemia&amp;action=edit&amp;section=21" title="Edit section: External links">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<ul>
<li><a rel="nofollow" class="external text" href="http://pubweb.fccc.edu/philadelphiachromosome/">50th Anniversary Symposium of Discovery (US)</a></li>
<li><a rel="nofollow" class="external text" href="http://www.nationalcmlsociety.org">The National CML Society (US)</a></li>
<li><a rel="nofollow" class="external text" href="http://www.cmleukemia.com/">CMLeukemia</a></li>
<li><a rel="nofollow" class="external text" href="http://www.cancer.org/docroot/CRI/CRI_2_3x.asp?dt=83">Chronic Myeloid Leukemia</a> at <a href="/wiki/American_Cancer_Society" title="American Cancer Society">American Cancer Society</a></li>
<li><a rel="nofollow" class="external text" href="http://www.leukemia-lymphoma.org/all_page?item_id=8501">CML information</a> from The Leukemia &amp; Lymphoma Society</li>
<li><i><a rel="nofollow" class="external text" href="http://www.merck.com/mmhe/sec14/ch176/ch176e.html">Chronic Myelocytic Leukemia (CML)</a></i> at <a href="/wiki/Merck_Manual_of_Diagnosis_and_Therapy" title="Merck Manual of Diagnosis and Therapy">Merck Manual of Diagnosis and Therapy</a> Home Edition</li>
<li><a rel="nofollow" class="external text" href="http://www.spirit-cml.org/spirit-2-home.aspx">SPIRIT 2 Website</a></li>
</ul>
<table class="navbox" style="border-spacing:0">
<tr>
<td style="padding:2px">
<table class="nowraplinks collapsible autocollapse navbox-inner" style="border-spacing:0;background:transparent;color:inherit">
<tr>
<th scope="col" class="navbox-title" colspan="2">
<div class="plainlinks hlist navbar mini">
<ul>
<li class="nv-view"><a href="/wiki/Template:Myeloid_malignancy" title="Template:Myeloid malignancy"><span title="View this template" style=";;background:none transparent;border:none;">v</span></a></li>
<li class="nv-talk"><a href="/wiki/Template_talk:Myeloid_malignancy" title="Template talk:Myeloid malignancy"><span title="Discuss this template" style=";;background:none transparent;border:none;">t</span></a></li>
<li class="nv-edit"><a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:Myeloid_malignancy&amp;action=edit"><span title="Edit this template" style=";;background:none transparent;border:none;">e</span></a></li>
</ul>
</div>
<div style="font-size:110%"><a href="/wiki/Myeloid" title="Myeloid">Myeloid</a> <a href="/wiki/Hematological_malignancy" title="Hematological malignancy" class="mw-redirect">hematological malignancy</a>/<a href="/wiki/Leukemia" title="Leukemia">leukemia</a> histology (<a href="/wiki/International_Classification_of_Diseases_for_Oncology" title="International Classification of Diseases for Oncology">ICD-O</a> 9590–9989, <a href="/wiki/ICD-10_Chapter_II:_Neoplasms#.28C81.E2.80.93C96.29_Malignant_neoplasms.2C_stated_or_presumed_to_be_primary.2C_of_lymphoid.2C_haematopoietic_and_related_tissue" title="ICD-10 Chapter II: Neoplasms">C81–C96</a>, <a href="/wiki/List_of_ICD-9_codes_140%E2%80%93239:_neoplasms#Malignant_neoplasm_of_lymphatic_and_hematopoietic_tissue_.28200.E2.80.93208.29" title="List of ICD-9 codes 140–239: neoplasms">200–208</a>)</div>
</th>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/CFU-GM" title="CFU-GM">CFU-GM</a>/<br />
and other <a href="/wiki/Granulocyte" title="Granulocyte">granulocytes</a></th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/CFU-GM" title="CFU-GM">CFU-GM</a></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Myelocyte" title="Myelocyte">Myelocyte</a></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group"><span style="font-weight:normal;"><i><a href="/wiki/Acute_myeloid_leukemia" title="Acute myeloid leukemia">AML</a>:</i></span></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Acute_myeloblastic_leukemia" title="Acute myeloblastic leukemia">Acute myeloblastic leukemia</a></li>
<li><a href="/wiki/Minimally_differentiated_acute_myeloblastic_leukemia" title="Minimally differentiated acute myeloblastic leukemia">M0</a></li>
<li><a href="/wiki/Acute_myeloblastic_leukemia_without_maturation" title="Acute myeloblastic leukemia without maturation">M1</a></li>
<li><a href="/wiki/Acute_myeloblastic_leukemia_with_maturation" title="Acute myeloblastic leukemia with maturation">M2</a></li>
<li><a href="/wiki/Acute_promyelocytic_leukemia" title="Acute promyelocytic leukemia">APL/M3</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><span style="font-weight:normal;"><i><a href="/wiki/Myeloproliferative_disease" title="Myeloproliferative disease" class="mw-redirect">MP</a></i></span></th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Chronic_neutrophilic_leukemia" title="Chronic neutrophilic leukemia">Chronic neutrophilic leukemia</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Monocyte" title="Monocyte">Monocyte</a></th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group"><span style="font-weight:normal;"><i><a href="/wiki/Acute_myeloid_leukemia" title="Acute myeloid leukemia">AML</a></i></span></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Acute_monocytic_leukemia" title="Acute monocytic leukemia">AMoL/M5</a></li>
<li><a href="/wiki/Acute_myeloid_dendritic_cell_leukemia" title="Acute myeloid dendritic cell leukemia">Myeloid dendritic cell leukemia</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><span style="font-weight:normal;"><i><strong class="selflink">CML</strong></i></span></th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Philadelphia_chromosome" title="Philadelphia chromosome">Philadelphia chromosome</a></li>
<li><a href="/wiki/Accelerated_phase_chronic_myelogenous_leukemia" title="Accelerated phase chronic myelogenous leukemia">Accelerated phase chronic myelogenous leukemia</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Myelomonocyte" title="Myelomonocyte">Myelomonocyte</a></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group"><span style="font-weight:normal;"><i><a href="/wiki/Acute_myeloid_leukemia" title="Acute myeloid leukemia">AML</a></i></span></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Acute_myelomonocytic_leukemia" title="Acute myelomonocytic leukemia">M4</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><span style="font-weight:normal;"><i><a href="/wiki/Myelodysplastic%E2%80%93myeloproliferative_diseases" title="Myelodysplastic–myeloproliferative diseases">MD-MP</a></i></span></th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Juvenile_myelomonocytic_leukemia" title="Juvenile myelomonocytic leukemia">Juvenile myelomonocytic leukemia</a></li>
<li><a href="/wiki/Chronic_myelomonocytic_leukemia" title="Chronic myelomonocytic leukemia">Chronic myelomonocytic leukemia</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Other</th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Histiocytosis" title="Histiocytosis">Histiocytosis</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/CFU-Baso" title="CFU-Baso">CFU-Baso</a></th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group"><span style="font-weight:normal;"><i><a href="/wiki/Acute_myeloid_leukemia" title="Acute myeloid leukemia">AML</a></i></span></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Acute_basophilic_leukemia" title="Acute basophilic leukemia">Acute basophilic</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/CFU-Eos" title="CFU-Eos">CFU-Eos</a></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group"><span style="font-weight:normal;"><i><a href="/wiki/Acute_myeloid_leukemia" title="Acute myeloid leukemia">AML</a></i></span></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Acute_eosinophilic_leukemia" title="Acute eosinophilic leukemia">Acute eosinophilic</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><span style="font-weight:normal;"><i><a href="/wiki/Myeloproliferative_disease" title="Myeloproliferative disease" class="mw-redirect">MP</a></i></span></th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Chronic_eosinophilic_leukemia" title="Chronic eosinophilic leukemia">Chronic eosinophilic leukemia</a>/<a href="/wiki/Hypereosinophilic_syndrome" title="Hypereosinophilic syndrome">Hypereosinophilic syndrome</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Megakaryocyte%E2%80%93erythroid_progenitor_cell" title="Megakaryocyte–erythroid progenitor cell">MEP</a></th>
<td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/CFU-Meg" title="CFU-Meg">CFU-Meg</a></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group"><span style="font-weight:normal;"><i><a href="/wiki/Acute_myeloid_leukemia" title="Acute myeloid leukemia">AML</a></i></span></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Acute_megakaryoblastic_leukemia" title="Acute megakaryoblastic leukemia">AMKL/M7</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><span style="font-weight:normal;"><i><a href="/wiki/Myeloproliferative_disease" title="Myeloproliferative disease" class="mw-redirect">MP</a></i></span></th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Essential_thrombocytosis" title="Essential thrombocytosis" class="mw-redirect">Essential thrombocytosis</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/CFU-E" title="CFU-E">CFU-E</a></th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group"><span style="font-weight:normal;"><i><a href="/wiki/Acute_myeloid_leukemia" title="Acute myeloid leukemia">AML</a></i></span></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Acute_erythroid_leukemia" title="Acute erythroid leukemia">Erythroleukemia/M6</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><span style="font-weight:normal;"><i><a href="/wiki/Myeloproliferative_disease" title="Myeloproliferative disease" class="mw-redirect">MP</a></i></span></th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Polycythemia_vera" title="Polycythemia vera">Polycythemia vera</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><span style="font-weight:normal;"><i><a href="/wiki/Myelodysplastic_syndrome" title="Myelodysplastic syndrome">MD</a></i></span></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Anemia" title="Anemia">Refractory anemia</a></li>
<li><a href="/wiki/Refractory_anemia_with_excess_of_blasts" title="Refractory anemia with excess of blasts">Refractory anemia with excess of blasts</a></li>
<li><a href="/wiki/Chromosome_5q_deletion_syndrome" title="Chromosome 5q deletion syndrome">Chromosome 5q deletion syndrome</a></li>
<li><a href="/wiki/Sideroblastic_anemia" title="Sideroblastic anemia">Sideroblastic anemia</a></li>
<li><a href="/wiki/Paroxysmal_nocturnal_hemoglobinuria" title="Paroxysmal nocturnal hemoglobinuria">Paroxysmal nocturnal hemoglobinuria</a></li>
<li><a href="/wiki/Refractory_cytopenia_with_multilineage_dysplasia" title="Refractory cytopenia with multilineage dysplasia">Refractory cytopenia with multilineage dysplasia</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/CFU-Mast" title="CFU-Mast">CFU-Mast</a></th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group"><span style="font-weight:normal;"><i><a href="/wiki/Mastocytoma" title="Mastocytoma">Mastocytoma</a></i></span></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Mast_cell_leukemia" title="Mast cell leukemia">Mast cell leukemia</a></li>
<li><a href="/wiki/Mast_cell_sarcoma" title="Mast cell sarcoma">Mast cell sarcoma</a></li>
<li><a href="/wiki/Mastocytosis" title="Mastocytosis">Systemic mastocytosis</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><span style="font-weight:normal;"><a href="/wiki/Mastocytosis" title="Mastocytosis">Mastocytosis</a>:</span></th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Diffuse_cutaneous_mastocytosis" title="Diffuse cutaneous mastocytosis">Diffuse cutaneous mastocytosis</a></li>
<li><a href="/wiki/Erythrodermic_mastocytosis" title="Erythrodermic mastocytosis">Erythrodermic mastocytosis</a></li>
<li><a href="/wiki/Adult_type_of_generalized_eruption_of_cutaneous_mastocytosis" title="Adult type of generalized eruption of cutaneous mastocytosis">Adult type of generalized eruption of cutaneous mastocytosis</a></li>
<li><a href="/wiki/Urticaria_pigmentosa" title="Urticaria pigmentosa">Urticaria pigmentosa</a></li>
<li><a href="/wiki/Mast_cell_sarcoma" title="Mast cell sarcoma">Mast cell sarcoma</a></li>
<li><a href="/wiki/Solitary_mastocytoma" title="Solitary mastocytoma">Solitary mastocytoma</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><span style="font-weight:normal;">Systemic mastocytosis</span></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Xanthelasmoidal_mastocytosis" title="Xanthelasmoidal mastocytosis">Xanthelasmoidal mastocytosis</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Multiple/unknown</th>
<td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group"><span style="font-weight:normal;"><i><a href="/wiki/Acute_myeloid_leukemia" title="Acute myeloid leukemia">AML</a></i></span></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Acute_panmyelosis_with_myelofibrosis" title="Acute panmyelosis with myelofibrosis">Acute panmyelosis with myelofibrosis</a></li>
<li><a href="/wiki/Myeloid_sarcoma" title="Myeloid sarcoma">Myeloid sarcoma</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><span style="font-weight:normal;"><i><a href="/wiki/Myeloproliferative_disease" title="Myeloproliferative disease" class="mw-redirect">MP</a></i></span></th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Myelofibrosis" title="Myelofibrosis">Myelofibrosis</a></li>
<li><a href="/wiki/Acute_biphenotypic_leukaemia" title="Acute biphenotypic leukaemia">Acute biphenotypic leukaemia</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<td class="navbox-abovebelow" colspan="2" style="background: transparent; padding: 0px;">
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="col" class="navbox-title" colspan="2">
<div class="plainlinks hlist navbar mini">
<ul>
<li class="nv-view"><a href="/wiki/Template:Myeloid_navs" title="Template:Myeloid navs"><span title="View this template" style=";;background:none transparent;border:none;">v</span></a></li>
<li class="nv-talk"><a href="/wiki/Template_talk:Myeloid_navs" title="Template talk:Myeloid navs"><span title="Discuss this template" style=";;background:none transparent;border:none;">t</span></a></li>
<li class="nv-edit"><a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:Myeloid_navs&amp;action=edit"><span title="Edit this template" style=";;background:none transparent;border:none;">e</span></a></li>
</ul>
</div>
<div style="font-size:110%">Index of <a href="/wiki/Myeloid" title="Myeloid">cells from bone marrow</a></div>
</th>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Description</th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Template:Myeloid_innate_immune_system" title="Template:Myeloid innate immune system">Immune system</a></li>
<li><a href="/wiki/Template:Myeloid_blood_cells_and_plasma" title="Template:Myeloid blood cells and plasma">Cells</a></li>
<li><a href="/wiki/Template:Myeloid_physiology" title="Template:Myeloid physiology">Physiology</a>
<ul>
<li><a href="/wiki/Template:Coagulation" title="Template:Coagulation">coagulation</a></li>
<li><a href="/wiki/Template:Hemeproteins" title="Template:Hemeproteins">proteins</a></li>
<li><a href="/wiki/Template:Granule_contents" title="Template:Granule contents">granule contents</a></li>
<li><a href="/wiki/Template:Colony-stimulating_factors" title="Template:Colony-stimulating factors">colony-stimulating</a></li>
<li>heme and porphyrin
<ul>
<li><i><a href="/wiki/Template:Porphyrin_metabolism_enzymes" title="Template:Porphyrin metabolism enzymes">metabolism</a></i></li>
<li><i><a href="/wiki/Template:Heme_metabolism_intermediates" title="Template:Heme metabolism intermediates">intermediates</a></i></li>
</ul>
</li>
</ul>
</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Disease</th>
<td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Template:Diseases_of_RBCs_and_megakaryocytes" title="Template:Diseases of RBCs and megakaryocytes">Red blood cell</a></li>
<li><a href="/wiki/Template:Monocyte_and_granulocyte_disease" title="Template:Monocyte and granulocyte disease">Monocyte and granulocyte</a></li>
<li><a href="/wiki/Template:Myeloid_malignancy" title="Template:Myeloid malignancy">Neoplasms and cancer</a></li>
<li><a href="/wiki/Template:Histiocytosis" title="Template:Histiocytosis">Histiocytosis</a></li>
<li><a href="/wiki/Template:Cardiovascular_system_symptoms_and_signs" title="Template:Cardiovascular system symptoms and signs">Symptoms and signs</a>
<ul>
<li><a href="/wiki/Template:Eponymous_medical_signs_for_hematology" title="Template:Eponymous medical signs for hematology">eponymous</a></li>
</ul>
</li>
<li><a href="/wiki/Template:Myeloid_blood_tests" title="Template:Myeloid blood tests">Blood tests</a>
<ul>
<li><a href="/wiki/Template:Abnormal_clinical_and_laboratory_findings_for_blood" title="Template:Abnormal clinical and laboratory findings for blood">findings</a></li>
</ul>
</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Treatment</th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Template:Transfusion_medicine" title="Template:Transfusion medicine">Transfusion</a></li>
<li>Drugs
<ul>
<li><a href="/wiki/Template:Antithrombotics" title="Template:Antithrombotics">thrombosis</a></li>
<li><a href="/wiki/Template:Antihemorrhagics" title="Template:Antihemorrhagics">bleeding</a></li>
<li><a href="/wiki/Template:B03,_B05,_B06" title="Template:B03, B05, B06">other</a></li>
</ul>
</li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
</table>
</td>
</tr>
</table>
<table class="navbox" style="border-spacing:0">
<tr>
<td style="padding:2px">
<table class="nowraplinks hlist navbox-inner" style="border-spacing:0;background:transparent;color:inherit">
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Help:Authority_control" title="Help:Authority control">Authority control</a></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/National_Diet_Library" title="National Diet Library">NDL</a>: <span class="uid"><a rel="nofollow" class="external text" href="http://id.ndl.go.jp/auth/ndlna/01217349">01217349</a></span></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
</table>


<!-- 
NewPP limit report
Parsed by mw1207
CPU time usage: 0.562 seconds
Real time usage: 0.660 seconds
Preprocessor visited node count: 2805/1000000
Preprocessor generated node count: 0/1500000
Post‐expand include size: 179631/2097152 bytes
Template argument size: 1744/2097152 bytes
Highest expansion depth: 11/40
Expensive parser function count: 2/500
Lua time usage: 0.220/10.000 seconds
Lua memory usage: 4.2 MB/50 MB
-->

<!-- 
Transclusion expansion time report (%,ms,calls,template)
100.00%  502.134      1 - -total
 41.82%  209.974      1 - Template:Reflist
 33.31%  167.281     14 - Template:Navbox
 17.97%   90.243      1 - Template:Infobox_disease
 16.19%   81.303     19 - Template:Cite_journal
 16.10%   80.843      1 - Template:Infobox
 14.90%   74.837      1 - Template:Myeloid_malignancy
 10.52%   52.846      7 - Template:Cite_web
  7.37%   37.008      1 - Template:Expand_section
  6.16%   30.931      1 - Template:Ambox
-->

<!-- Saved in parser cache with key enwiki:pcache:idhash:559874-0!*!0!!en!4!* and timestamp 20150711000911 and revision id 669549241
 -->
<noscript><img src="//en.wikipedia.org/wiki/Special:CentralAutoLogin/start?type=1x1" alt="" title="" width="1" height="1" style="border: none; position: absolute;" /></noscript></div>					<div class="printfooter">
						Retrieved from "<a dir="ltr" href="https://en.wikipedia.org/w/index.php?title=Chronic_myelogenous_leukemia&amp;oldid=669549241">https://en.wikipedia.org/w/index.php?title=Chronic_myelogenous_leukemia&amp;oldid=669549241</a>"					</div>
				<div id='catlinks' class='catlinks'><div id="mw-normal-catlinks" class="mw-normal-catlinks"><a href="/wiki/Help:Category" title="Help:Category">Categories</a>: <ul><li><a href="/wiki/Category:Chronic_myeloid_leukemia" title="Category:Chronic myeloid leukemia">Chronic myeloid leukemia</a></li></ul></div><div id="mw-hidden-catlinks" class="mw-hidden-catlinks mw-hidden-cats-hidden">Hidden categories: <ul><li><a href="/wiki/Category:Articles_with_inconsistent_citation_formats" title="Category:Articles with inconsistent citation formats">Articles with inconsistent citation formats</a></li><li><a href="/wiki/Category:Articles_with_contributors_link" title="Category:Articles with contributors link">Articles with contributors link</a></li><li><a href="/wiki/Category:Articles_to_be_expanded_from_August_2012" title="Category:Articles to be expanded from August 2012">Articles to be expanded from August 2012</a></li><li><a href="/wiki/Category:All_articles_to_be_expanded" title="Category:All articles to be expanded">All articles to be expanded</a></li><li><a href="/wiki/Category:All_articles_with_unsourced_statements" title="Category:All articles with unsourced statements">All articles with unsourced statements</a></li><li><a href="/wiki/Category:Articles_with_unsourced_statements_from_December_2012" title="Category:Articles with unsourced statements from December 2012">Articles with unsourced statements from December 2012</a></li><li><a href="/wiki/Category:Articles_that_use_a_Medicine_navs_subtemplate" title="Category:Articles that use a Medicine navs subtemplate">Articles that use a Medicine navs subtemplate</a></li></ul></div></div>				<div class="visualClear"></div>
							</div>
		</div>
		<div id="mw-navigation">
			<h2>Navigation menu</h2>

			<div id="mw-head">
									<div id="p-personal" role="navigation" class="" aria-labelledby="p-personal-label">
						<h3 id="p-personal-label">Personal tools</h3>
						<ul>
							<li id="pt-createaccount"><a href="/w/index.php?title=Special:UserLogin&amp;returnto=Chronic+myelogenous+leukemia&amp;type=signup" title="You are encouraged to create an account and log in; however, it is not mandatory">Create account</a></li><li id="pt-login"><a href="/w/index.php?title=Special:UserLogin&amp;returnto=Chronic+myelogenous+leukemia" title="You're encouraged to log in; however, it's not mandatory. [o]" accesskey="o">Log in</a></li>						</ul>
					</div>
									<div id="left-navigation">
										<div id="p-namespaces" role="navigation" class="vectorTabs" aria-labelledby="p-namespaces-label">
						<h3 id="p-namespaces-label">Namespaces</h3>
						<ul>
															<li  id="ca-nstab-main" class="selected"><span><a href="/wiki/Chronic_myelogenous_leukemia"  title="View the content page [c]" accesskey="c">Article</a></span></li>
															<li  id="ca-talk"><span><a href="/wiki/Talk:Chronic_myelogenous_leukemia"  title="Discussion about the content page [t]" accesskey="t" rel="discussion">Talk</a></span></li>
													</ul>
					</div>
										<div id="p-variants" role="navigation" class="vectorMenu emptyPortlet" aria-labelledby="p-variants-label">
												<h3 id="p-variants-label">
							<span>Variants</span><a href="#"></a>
						</h3>

						<div class="menu">
							<ul>
															</ul>
						</div>
					</div>
									</div>
				<div id="right-navigation">
										<div id="p-views" role="navigation" class="vectorTabs" aria-labelledby="p-views-label">
						<h3 id="p-views-label">Views</h3>
						<ul>
															<li id="ca-view" class="selected"><span><a href="/wiki/Chronic_myelogenous_leukemia" >Read</a></span></li>
															<li id="ca-edit"><span><a href="/w/index.php?title=Chronic_myelogenous_leukemia&amp;action=edit"  title="Edit this page [e]" accesskey="e">Edit</a></span></li>
															<li id="ca-history" class="collapsible"><span><a href="/w/index.php?title=Chronic_myelogenous_leukemia&amp;action=history"  title="Past versions of this page [h]" accesskey="h">View history</a></span></li>
													</ul>
					</div>
										<div id="p-cactions" role="navigation" class="vectorMenu emptyPortlet" aria-labelledby="p-cactions-label">
						<h3 id="p-cactions-label"><span>More</span><a href="#"></a></h3>

						<div class="menu">
							<ul>
															</ul>
						</div>
					</div>
										<div id="p-search" role="search">
						<h3>
							<label for="searchInput">Search</label>
						</h3>

						<form action="/w/index.php" id="searchform">
							<div id="simpleSearch">
							<input type="search" name="search" placeholder="Search" title="Search Wikipedia [f]" accesskey="f" id="searchInput" /><input type="hidden" value="Special:Search" name="title" /><input type="submit" name="fulltext" value="Search" title="Search Wikipedia for this text" id="mw-searchButton" class="searchButton mw-fallbackSearchButton" /><input type="submit" name="go" value="Go" title="Go to a page with this exact name if one exists" id="searchButton" class="searchButton" />							</div>
						</form>
					</div>
									</div>
			</div>
			<div id="mw-panel">
				<div id="p-logo" role="banner"><a class="mw-wiki-logo" href="/wiki/Main_Page"  title="Visit the main page"></a></div>
						<div class="portal" role="navigation" id='p-navigation' aria-labelledby='p-navigation-label'>
			<h3 id='p-navigation-label'>Navigation</h3>

			<div class="body">
									<ul>
						<li id="n-mainpage-description"><a href="/wiki/Main_Page" title="Visit the main page [z]" accesskey="z">Main page</a></li><li id="n-contents"><a href="/wiki/Portal:Contents" title="Guides to browsing Wikipedia">Contents</a></li><li id="n-featuredcontent"><a href="/wiki/Portal:Featured_content" title="Featured content – the best of Wikipedia">Featured content</a></li><li id="n-currentevents"><a href="/wiki/Portal:Current_events" title="Find background information on current events">Current events</a></li><li id="n-randompage"><a href="/wiki/Special:Random" title="Load a random article [x]" accesskey="x">Random article</a></li><li id="n-sitesupport"><a href="https://donate.wikimedia.org/wiki/Special:FundraiserRedirector?utm_source=donate&amp;utm_medium=sidebar&amp;utm_campaign=C13_en.wikipedia.org&amp;uselang=en" title="Support us">Donate to Wikipedia</a></li><li id="n-shoplink"><a href="//shop.wikimedia.org" title="Visit the Wikimedia Shop">Wikipedia store</a></li>					</ul>
							</div>
		</div>
			<div class="portal" role="navigation" id='p-interaction' aria-labelledby='p-interaction-label'>
			<h3 id='p-interaction-label'>Interaction</h3>

			<div class="body">
									<ul>
						<li id="n-help"><a href="/wiki/Help:Contents" title="Guidance on how to use and edit Wikipedia">Help</a></li><li id="n-aboutsite"><a href="/wiki/Wikipedia:About" title="Find out about Wikipedia">About Wikipedia</a></li><li id="n-portal"><a href="/wiki/Wikipedia:Community_portal" title="About the project, what you can do, where to find things">Community portal</a></li><li id="n-recentchanges"><a href="/wiki/Special:RecentChanges" title="A list of recent changes in the wiki [r]" accesskey="r">Recent changes</a></li><li id="n-contactpage"><a href="//en.wikipedia.org/wiki/Wikipedia:Contact_us">Contact page</a></li>					</ul>
							</div>
		</div>
			<div class="portal" role="navigation" id='p-tb' aria-labelledby='p-tb-label'>
			<h3 id='p-tb-label'>Tools</h3>

			<div class="body">
									<ul>
						<li id="t-whatlinkshere"><a href="/wiki/Special:WhatLinksHere/Chronic_myelogenous_leukemia" title="List of all English Wikipedia pages containing links to this page [j]" accesskey="j">What links here</a></li><li id="t-recentchangeslinked"><a href="/wiki/Special:RecentChangesLinked/Chronic_myelogenous_leukemia" title="Recent changes in pages linked from this page [k]" accesskey="k">Related changes</a></li><li id="t-upload"><a href="/wiki/Wikipedia:File_Upload_Wizard" title="Upload files [u]" accesskey="u">Upload file</a></li><li id="t-specialpages"><a href="/wiki/Special:SpecialPages" title="A list of all special pages [q]" accesskey="q">Special pages</a></li><li id="t-permalink"><a href="/w/index.php?title=Chronic_myelogenous_leukemia&amp;oldid=669549241" title="Permanent link to this revision of the page">Permanent link</a></li><li id="t-info"><a href="/w/index.php?title=Chronic_myelogenous_leukemia&amp;action=info" title="More information about this page">Page information</a></li><li id="t-wikibase"><a href="//www.wikidata.org/wiki/Q729735" title="Link to connected data repository item [g]" accesskey="g">Wikidata item</a></li><li id="t-cite"><a href="/w/index.php?title=Special:CiteThisPage&amp;page=Chronic_myelogenous_leukemia&amp;id=669549241" title="Information on how to cite this page">Cite this page</a></li>					</ul>
							</div>
		</div>
			<div class="portal" role="navigation" id='p-coll-print_export' aria-labelledby='p-coll-print_export-label'>
			<h3 id='p-coll-print_export-label'>Print/export</h3>

			<div class="body">
									<ul>
						<li id="coll-create_a_book"><a href="/w/index.php?title=Special:Book&amp;bookcmd=book_creator&amp;referer=Chronic+myelogenous+leukemia">Create a book</a></li><li id="coll-download-as-rdf2latex"><a href="/w/index.php?title=Special:Book&amp;bookcmd=render_article&amp;arttitle=Chronic+myelogenous+leukemia&amp;oldid=669549241&amp;writer=rdf2latex">Download as PDF</a></li><li id="t-print"><a href="/w/index.php?title=Chronic_myelogenous_leukemia&amp;printable=yes" title="Printable version of this page [p]" accesskey="p">Printable version</a></li>					</ul>
							</div>
		</div>
			<div class="portal" role="navigation" id='p-lang' aria-labelledby='p-lang-label'>
			<h3 id='p-lang-label'>Languages</h3>

			<div class="body">
									<ul>
						<li class="interlanguage-link interwiki-ar"><a href="//ar.wikipedia.org/wiki/%D8%A7%D8%A8%D9%8A%D8%B6%D8%A7%D8%B6_%D8%A7%D9%84%D8%AF%D9%85_%D8%A7%D9%84%D9%86%D9%82%D9%88%D9%8A_%D8%A7%D9%84%D9%85%D8%B2%D9%85%D9%86" title="ابيضاض الدم النقوي المزمن – Arabic" lang="ar" hreflang="ar">العربية</a></li><li class="interlanguage-link interwiki-ca"><a href="//ca.wikipedia.org/wiki/Leuc%C3%A8mia_mieloide_cr%C3%B2nica" title="Leucèmia mieloide crònica – Catalan" lang="ca" hreflang="ca">Català</a></li><li class="interlanguage-link interwiki-de badge-Q17437798 badge-goodarticle" title="good article"><a href="//de.wikipedia.org/wiki/Chronische_myeloische_Leuk%C3%A4mie" title="Chronische myeloische Leukämie – German" lang="de" hreflang="de">Deutsch</a></li><li class="interlanguage-link interwiki-es"><a href="//es.wikipedia.org/wiki/Leucemia_mieloide_cr%C3%B3nica" title="Leucemia mieloide crónica – Spanish" lang="es" hreflang="es">Español</a></li><li class="interlanguage-link interwiki-fa"><a href="//fa.wikipedia.org/wiki/%D9%84%D9%88%D8%B3%D9%85%DB%8C_%D9%85%D8%B2%D9%85%D9%86_%D9%85%DB%8C%D9%84%D9%88%D8%A6%DB%8C%D8%AF%DB%8C" title="لوسمی مزمن میلوئیدی – Persian" lang="fa" hreflang="fa">فارسی</a></li><li class="interlanguage-link interwiki-fr"><a href="//fr.wikipedia.org/wiki/Leuc%C3%A9mie_my%C3%A9lo%C3%AFde_chronique" title="Leucémie myéloïde chronique – French" lang="fr" hreflang="fr">Français</a></li><li class="interlanguage-link interwiki-ko"><a href="//ko.wikipedia.org/wiki/%EB%A7%8C%EC%84%B1_%EA%B3%A8%EC%88%98%EC%84%B1_%EB%B0%B1%ED%98%88%EB%B3%91" title="만성 골수성 백혈병 – Korean" lang="ko" hreflang="ko">한국어</a></li><li class="interlanguage-link interwiki-it"><a href="//it.wikipedia.org/wiki/Leucemia_mieloide_cronica" title="Leucemia mieloide cronica – Italian" lang="it" hreflang="it">Italiano</a></li><li class="interlanguage-link interwiki-he"><a href="//he.wikipedia.org/wiki/%D7%9C%D7%95%D7%A7%D7%9E%D7%99%D7%94_%D7%9E%D7%99%D7%90%D7%9C%D7%95%D7%90%D7%99%D7%93%D7%99%D7%AA_%D7%9B%D7%A8%D7%95%D7%A0%D7%99%D7%AA" title="לוקמיה מיאלואידית כרונית – Hebrew" lang="he" hreflang="he">עברית</a></li><li class="interlanguage-link interwiki-kk"><a href="//kk.wikipedia.org/wiki/%D0%A1%D0%BE%D0%B7%D1%8B%D0%BB%D0%BC%D0%B0%D0%BB%D1%8B_%D0%BC%D0%B8%D0%B5%D0%BB%D0%BE%D0%BB%D0%B5%D0%B9%D0%BA%D0%BE%D0%B7" title="Созылмалы миелолейкоз – Kazakh" lang="kk" hreflang="kk">Қазақша</a></li><li class="interlanguage-link interwiki-lt"><a href="//lt.wikipedia.org/wiki/L%C4%97tin%C4%97_mieloleukemija" title="Lėtinė mieloleukemija – Lithuanian" lang="lt" hreflang="lt">Lietuvių</a></li><li class="interlanguage-link interwiki-hu"><a href="//hu.wikipedia.org/wiki/Kr%C3%B3nikus_mieloid_leuk%C3%A9mia" title="Krónikus mieloid leukémia – Hungarian" lang="hu" hreflang="hu">Magyar</a></li><li class="interlanguage-link interwiki-ms"><a href="//ms.wikipedia.org/wiki/Leukemia_mielogenus_kronik" title="Leukemia mielogenus kronik – Malay" lang="ms" hreflang="ms">Bahasa Melayu</a></li><li class="interlanguage-link interwiki-mwl"><a href="//mwl.wikipedia.org/wiki/Leucemia_mieloide_cr%C3%B3nica" title="Leucemia mieloide crónica – Mirandese" lang="mwl" hreflang="mwl">Mirandés</a></li><li class="interlanguage-link interwiki-nl"><a href="//nl.wikipedia.org/wiki/Chronische_myelo%C3%AFde_leukemie" title="Chronische myeloïde leukemie – Dutch" lang="nl" hreflang="nl">Nederlands</a></li><li class="interlanguage-link interwiki-ja"><a href="//ja.wikipedia.org/wiki/%E6%85%A2%E6%80%A7%E9%AA%A8%E9%AB%84%E6%80%A7%E7%99%BD%E8%A1%80%E7%97%85" title="慢性骨髄性白血病 – Japanese" lang="ja" hreflang="ja">日本語</a></li><li class="interlanguage-link interwiki-no"><a href="//no.wikipedia.org/wiki/Kronisk_myelogen_leukemi" title="Kronisk myelogen leukemi – Norwegian" lang="no" hreflang="no">Norsk bokmål</a></li><li class="interlanguage-link interwiki-pl"><a href="//pl.wikipedia.org/wiki/Przewlek%C5%82a_bia%C5%82aczka_szpikowa" title="Przewlekła białaczka szpikowa – Polish" lang="pl" hreflang="pl">Polski</a></li><li class="interlanguage-link interwiki-pt"><a href="//pt.wikipedia.org/wiki/Leucemia_mieloide_cr%C3%B4nica" title="Leucemia mieloide crônica – Portuguese" lang="pt" hreflang="pt">Português</a></li><li class="interlanguage-link interwiki-ru"><a href="//ru.wikipedia.org/wiki/%D0%A5%D1%80%D0%BE%D0%BD%D0%B8%D1%87%D0%B5%D1%81%D0%BA%D0%B8%D0%B9_%D0%BC%D0%B8%D0%B5%D0%BB%D0%BE%D0%B8%D0%B4%D0%BD%D1%8B%D0%B9_%D0%BB%D0%B5%D0%B9%D0%BA%D0%BE%D0%B7" title="Хронический миелоидный лейкоз – Russian" lang="ru" hreflang="ru">Русский</a></li><li class="interlanguage-link interwiki-simple"><a href="//simple.wikipedia.org/wiki/Chronic_myeloid_leukemia" title="Chronic myeloid leukemia – Simple English" lang="simple" hreflang="simple">Simple English</a></li><li class="interlanguage-link interwiki-sl"><a href="//sl.wikipedia.org/wiki/Kroni%C4%8Dna_mieloi%C4%8Dna_levkemija" title="Kronična mieloična levkemija – Slovenian" lang="sl" hreflang="sl">Slovenščina</a></li><li class="interlanguage-link interwiki-sr"><a href="//sr.wikipedia.org/wiki/Hroni%C4%8Dna_mijeloidna_leukemija" title="Hronična mijeloidna leukemija – Serbian" lang="sr" hreflang="sr">Српски / srpski</a></li><li class="interlanguage-link interwiki-sh"><a href="//sh.wikipedia.org/wiki/Hroni%C4%8Dna_mijeloidna_leukemija" title="Hronična mijeloidna leukemija – Serbo-Croatian" lang="sh" hreflang="sh">Srpskohrvatski / српскохрватски</a></li><li class="interlanguage-link interwiki-fi"><a href="//fi.wikipedia.org/wiki/Krooninen_myelooinen_leukemia" title="Krooninen myelooinen leukemia – Finnish" lang="fi" hreflang="fi">Suomi</a></li><li class="interlanguage-link interwiki-sv"><a href="//sv.wikipedia.org/wiki/Kronisk_myeloisk_leukemi" title="Kronisk myeloisk leukemi – Swedish" lang="sv" hreflang="sv">Svenska</a></li><li class="interlanguage-link interwiki-th"><a href="//th.wikipedia.org/wiki/%E0%B8%A1%E0%B8%B0%E0%B9%80%E0%B8%A3%E0%B9%87%E0%B8%87%E0%B9%80%E0%B8%A1%E0%B9%87%E0%B8%94%E0%B9%80%E0%B8%A5%E0%B8%B7%E0%B8%AD%E0%B8%94%E0%B8%82%E0%B8%B2%E0%B8%A7%E0%B9%80%E0%B8%A3%E0%B8%B7%E0%B9%89%E0%B8%AD%E0%B8%A3%E0%B8%B1%E0%B8%87%E0%B8%8A%E0%B8%99%E0%B8%B4%E0%B8%94%E0%B9%84%E0%B8%A1%E0%B8%AD%E0%B8%B4%E0%B8%A5%E0%B8%AD%E0%B8%A2%E0%B8%94%E0%B9%8C" title="มะเร็งเม็ดเลือดขาวเรื้อรังชนิดไมอิลอยด์ – Thai" lang="th" hreflang="th">ไทย</a></li><li class="interlanguage-link interwiki-uk"><a href="//uk.wikipedia.org/wiki/%D0%A5%D1%80%D0%BE%D0%BD%D1%96%D1%87%D0%BD%D0%B8%D0%B9_%D0%BC%D1%96%D1%94%D0%BB%D0%BE%D1%86%D0%B8%D1%82%D0%B0%D1%80%D0%BD%D0%B8%D0%B9_%D0%BB%D0%B5%D0%B9%D0%BA%D0%BE%D0%B7" title="Хронічний мієлоцитарний лейкоз – Ukrainian" lang="uk" hreflang="uk">Українська</a></li><li class="interlanguage-link interwiki-zh"><a href="//zh.wikipedia.org/wiki/%E6%85%A2%E6%80%A7%E7%B2%92%E7%BB%86%E8%83%9E%E6%80%A7%E7%99%BD%E8%A1%80%E7%97%85" title="慢性粒细胞性白血病 – Chinese" lang="zh" hreflang="zh">中文</a></li><li class="uls-p-lang-dummy"><a href="#"></a></li>					</ul>
				<div class='after-portlet after-portlet-lang'><span class="wb-langlinks-edit wb-langlinks-link"><a href="//www.wikidata.org/wiki/Q729735#sitelinks-wikipedia" title="Edit interlanguage links" class="wbc-editpage">Edit links</a></span></div>			</div>
		</div>
				</div>
		</div>
		<div id="footer" role="contentinfo">
							<ul id="footer-info">
											<li id="footer-info-lastmod"> This page was last modified on 1 July 2015, at 22:55.</li>
											<li id="footer-info-copyright">Text is available under the <a rel="license" href="//en.wikipedia.org/wiki/Wikipedia:Text_of_Creative_Commons_Attribution-ShareAlike_3.0_Unported_License">Creative Commons Attribution-ShareAlike License</a><a rel="license" href="//creativecommons.org/licenses/by-sa/3.0/" style="display:none;"></a>;
additional terms may apply.  By using this site, you agree to the <a href="//wikimediafoundation.org/wiki/Terms_of_Use">Terms of Use</a> and <a href="//wikimediafoundation.org/wiki/Privacy_policy">Privacy Policy</a>. Wikipedia® is a registered trademark of the <a href="//www.wikimediafoundation.org/">Wikimedia Foundation, Inc.</a>, a non-profit organization.</li>
									</ul>
							<ul id="footer-places">
											<li id="footer-places-privacy"><a href="//wikimediafoundation.org/wiki/Privacy_policy" title="wikimedia:Privacy policy">Privacy policy</a></li>
											<li id="footer-places-about"><a href="/wiki/Wikipedia:About" title="Wikipedia:About">About Wikipedia</a></li>
											<li id="footer-places-disclaimer"><a href="/wiki/Wikipedia:General_disclaimer" title="Wikipedia:General disclaimer">Disclaimers</a></li>
											<li id="footer-places-contact"><a href="//en.wikipedia.org/wiki/Wikipedia:Contact_us">Contact Wikipedia</a></li>
											<li id="footer-places-developers"><a href="https://www.mediawiki.org/wiki/Special:MyLanguage/How_to_contribute">Developers</a></li>
											<li id="footer-places-mobileview"><a href="//en.m.wikipedia.org/w/index.php?title=Chronic_myelogenous_leukemia&amp;mobileaction=toggle_view_mobile" class="noprint stopMobileRedirectToggle">Mobile view</a></li>
									</ul>
										<ul id="footer-icons" class="noprint">
											<li id="footer-copyrightico">
							<a href="//wikimediafoundation.org/"><img src="/static/images/wikimedia-button.png" srcset="/static/images/wikimedia-button-1.5x.png 1.5x, /static/images/wikimedia-button-2x.png 2x" width="88" height="31" alt="Wikimedia Foundation"/></a>						</li>
											<li id="footer-poweredbyico">
							<a href="//www.mediawiki.org/"><img src="//en.wikipedia.org/static/1.26wmf13/resources/assets/poweredby_mediawiki_88x31.png" alt="Powered by MediaWiki" srcset="//en.wikipedia.org/static/1.26wmf13/resources/assets/poweredby_mediawiki_132x47.png 1.5x, //en.wikipedia.org/static/1.26wmf13/resources/assets/poweredby_mediawiki_176x62.png 2x" width="88" height="31" /></a>						</li>
									</ul>
						<div style="clear:both"></div>
		</div>
		<script>if(window.jQuery)jQuery.ready();</script><script>if(window.mw){
mw.loader.state({"ext.globalCssJs.site":"ready","ext.globalCssJs.user":"ready","site":"loading","user":"ready","user.groups":"ready"});
}</script>
<link rel="stylesheet" href="//en.wikipedia.org/w/load.php?debug=false&amp;lang=en&amp;modules=ext.cite.styles%7Cext.gadget.DRN-wizard%2CReferenceTooltips%2CWatchlistGreenIndicators%2Ccharinsert%2Cfeatured-articles-links%2CrefToolbar%2Cswitcher%2Cteahouse%7Cext.wikimediaBadges&amp;only=styles&amp;skin=vector&amp;*" />
<script>if(window.mw){
mw.loader.load(["ext.cite.a11y","mediawiki.toc","mediawiki.action.view.postEdit","mediawiki.user","mediawiki.hidpi","mediawiki.page.ready","mediawiki.searchSuggest","ext.cirrusSearch.loggingSchema","mmv.bootstrap.autostart","ext.imageMetrics.loader","ext.eventLogging.subscriber","ext.wikimediaEvents","ext.wikimediaEvents.statsd","ext.navigationTiming","ext.gadget.teahouse","ext.gadget.ReferenceTooltips","ext.gadget.WatchlistGreenIndicators","ext.gadget.DRN-wizard","ext.gadget.charinsert","ext.gadget.refToolbar","ext.gadget.switcher","ext.gadget.featured-articles-links","ext.visualEditor.targetLoader","schema.UniversalLanguageSelector","ext.uls.eventlogger","ext.uls.interlanguage"],null,true);
}</script>
<script>if(window.mw){
document.write("\u003Cscript src=\"//en.wikipedia.org/w/load.php?debug=false\u0026amp;lang=en\u0026amp;modules=site\u0026amp;only=scripts\u0026amp;skin=vector\u0026amp;*\"\u003E\u003C/script\u003E");
}</script>
<script>if(window.mw){
mw.config.set({"wgBackendResponseTime":115,"wgHostname":"mw1097"});
}</script>
	</body>
</html>
